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ABSTRACT	
	
	
	
Gregoriades,	Jeannine	Marie	Crum.	Ph.D.,	Biomedical	Sciences	PhD	Program,	Wright	State	
University,	2017.	Functions	of	the	apical	Na+/K+/2Cl-	Cotransporter	1	in	choroid	plexus	
epithelial	cells.	
	
	
	
Choroid	plexus	epithelial	cells	(CPECs)	secrete	cerebrospinal	fluid	(CSF)	and	regulate	its	
electrolyte	composition.		CPECs	express	both	the	Na+/K+	ATPase	and	the	Na+/K+/2Cl-
cotransporter	1	(NKCC1)	on	their	apical	membrane	(CSF	facing),	deviating	from	the	typical	
basolateral	membrane	location	in	chloride	secretory	epithelia.		Given	this	unusual	location	
of	NKCC1	and	the	unknown	intracellular	Na+	and	Cl-	concentrations	of	CPECs,	the	
cotransporter	function	in	these	cells	is	not	understood.	Further,	the	direction	of	net	ion	and	
associated	water	fluxes	mediated	by	NKCC1	under	basal	physiological	conditions	in	CPECs	
is	controversial.		Determining	the	direction	of	NKCC1-	mediated	fluxes	is	critical	to	
understanding	the	function	of	this	cotransporter	in	CPECs.		If	NKCC1	works	in	the	net	efflux	
mode,	it	may	be	involved	in	CSF	secretion	as	suggested	by	some	investigators.	Conversely,	if	
NKCC1	works	in	the	net	influx	mode,	as	it	does	in	the	basolateral	membrane	of	other	
chloride	secreting	epithelia,	then	it	would	have	an	absorptive	function	in	CPECs	and	could	
be	involved	in	CSF	K+	regulation,	as	we	and	others	propose.	NKCC1-mediated	ion	and	water	
fluxes	are	tightly	linked;	thus,	their	direction	is	inferred	by	measuring	cell	water	volume	
(CWV)	changes	in	calcein-loaded	CPECs	following	NKCC1	inactivation.	Both	genetic	and	
pharmacological	inactivation	of	NKCC1	produces	CPEC	shrinkage	of	~16	%,	due	to	
unbalanced	solute	and	water	effluxes.	[Na+]i	and	[Cl-]i	measurements	using	the	fluorescent	
	 v	
indicator	dyes	ANG-2	and	MQAE	show	that	[Na+]i	=	8.4	±	1.0	mM	and	[Cl-]i	=	62.1	±	3.5	mM.		
NKCC1	-/-	CPECs	have	~	50%	less	[Cl-]i	than	WT.	WT	CPECs	are	exquisitely	sensitive	to	
isosmotic	changes	in	[K+]o	(±	2	mM),	as	shown	by	CWV	responses.		CPECs	of	NKCC1-/-	
mouse	lose	the	response	to	[K+]o..		These	results	suggest	that	under	basal	conditions,	NKCC1	
is	constitutively	active	and	works	in	the	inward	mode	near	its	thermodynamic	equilibrium	
in	CPECS.	We	propose	NKCC1	has	absorptive	functions	and	contributes	to	the	maintenance	
of	normal	and	constant	CWV.		The	Km	for	[K+]o	and	the	thermodynamic	forces	driving	
NKCC1	transport	in	CPECs		suggest	that	it	functions	as	a	sensor	and	regulator	of	CSF	[K+].	
	 	
	 vi	
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Chapter	1:	Background	
Choroid	plexus	
	
The	choroid	plexus	epithelium	makes	up	the	blood-cerebrospinal	fluid-
barrier,	and	consists	of	a	monolayer	of	cuboidal	epithelial	cells	bound	together	by	
tight-junctions,	surrounding	highly-fenestrated	capillaries	that	maintain	an	
impressive	blood-flow	of	3	–5	ml/	min/	gram	(Damkier,	Brown,	&	Praetorius,	2010;	
Johanson,	Stopa,	&	McMillan,	2011).		On	the	apical	membrane,	choroid	plexus	
epithelial	cells	(CPECs)	have	beating	cilia	that	protrude	from	the	densely	packed	
microvilli	surface,	and	function	to	agitate	unstirred	layers	and	facilitate	
cerebrospinal	fluid	(CSF)	circulation	(Redzic	&	Segal,	2004).	A	convection	current/	
flow	of	CSF	is	generated	by	the	beating	cilia	on	CPECs	and	directs	the	CSF	from	the	
lateral	ventricles	through	the	third	and	fourth	ventricles,	and	around	the	spinal	cord	
and	brain	(Bulat	&	Klarica,	2011;	Damkier	et	al.,	2010).			Floating	in	the	brain	
ventricles,	the	choroid	plexus	epithelium	is	continuous	with	the	ependymal	cells	
lining	the	ventricles.		It	has	several	functions,	many	which	are	still	under	
investigation,	though	the	most	common	function	ascribed	to	the	choroid	plexus	is	
the	ability	to	secrete	CSF	(Praetorius	&	Damkier,	2017;	Spector,	Keep,	Robert	
Snodgrass,	Smith,	&	Johanson,	2015).		CSF	flows	through	the	ventricles	and	around	
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the	brain	and	spinal	cord,	freely	diffusing	with	the	interstitial	fluid	(ISF)	that	fills	the	
extracellular	spaces	between	neurons	and	glia.	Ependymal	cells	that	line	the	
cerebral	ventricles	are	very	permeable	and	allow	free	diffusion	of	small	solutes	
between	ventricular	CSF	and	brain	ISF	(Johanson	et	al.,	2008;	Johanson	et	al.,	2011).	
CPECs	maintain	a	net	efflux	of	Na+,	Cl-,	HCO3-,	and	H2O	into	the	ventricles,	while	
simultaneously	mediating	a	net	influx	of	K+	from	the	CSF	to	blood	(Brown,	Davies,	
Speake,	&	Millar,	2004;	Damkier	et	al.,	2010;	Husted	&	Reed,	1976;	Wright,	1978).		
	
Constantly	flowing	CSF	through	the	ventricles	provides	a	sink	for	excess	
extracellular	ions	(e.g.,	K+),	neurotransmitters,	metabolites,	and	other	waste	
products	to	diffuse	into	for	removal	by	the	choroid	plexus	(Brown	et	al.,	2004).		The	
choroid	plexus	absorbs	these	waste	products	from	the	CSF	and	transfers	them	to	the	
plasma	for	later	processing	by	the	kidney	(Johanson	et	al.,	2011).	This	leads	to	the	
choroid	plexus	being	coined	“the	kidney	of	the	brain”	(Spector	&	Johanson,	1989).	
Another	similarity	between	the	kidney	and	the	choroid	plexus	is	the	apical	
expression	of	a	Na+/	K+/	2Cl-	Cotransporter	(NKCC),	in	the	pattern	of	a	Cl-	absorptive	
epithelium	(Alvarez-Leefmans,	2012;	Russell,	2000;	Spector	&	Johanson,	1989).	In	
Cl-	absorbing	epithelia	(Figure	1.1B),	such	as	in	the	thick	ascending	limb	of	Henle’s	
loop	and	the	macula	densa	of	the	kidney,	NKCC2	is	expressed	on	the	apical	
membrane	and	Na+/K+	ATPase	(NKATP)	remains	on	the	basolateral	membrane	
(Alvarez-Leefmans,	2012).	However,	the	choroid	plexus	is	considered	a	chloride	
secreting	epithelium,	producing	CSF	with	a	higher	chloride	concentration	([Cl-])	
than	that	of	the	plasma	(Alvarez-Leefmans,	2012;	Brown	et	al.,	2004;	Wright,	1978).	
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In	Cl-	secreting	epithelia	(Figure	1.1A),	such	as	those	found	in	exocrine	glands	(e.g.,	
salivary	glands	or	tracheal	epithelium)	or	the	ciliary	body	of	the	eye,	NKATP	and	
NKCC1	are	expressed	in	the	basolateral	membrane	where	NKCC1	functions	as	a	Cl-	
loader	(Alvarez-Leefmans,	2012;	Hamann,	Herrera-Perez,	Zeuthen,	&	Alvarez-
Leefmans,	2010).		It	should	be	noted	that	in	both	Cl-	secreting	and	Cl-	absorbing	
epithelia,	NKCC-mediated	cotransport	occurs	in	the	net	influx	mode	(Figure	1.1A,	B).		
However,	in	CPECs	the	direction	of	net	ion	fluxes	mediated	by	NKCC1	is	uncertain	
(Figure	1.1C).	It	has	been	hypothesized	that	the	cotransporter	works	near	its	
thermodynamic	equilibrium	given	the	low	CSF	[K+],	approximately	2.9	–3.0	mM,	
which	may	favor	the	cotransporter	to	fluctuate	between	inward-directed	and	
outward-directed	modes	(Keep,	Xiang,	&	Betz,	1994).	The	uncertainty	regarding	
NKCC1	cotransport	direction	is	the	result	of	its	unusual	apical	location	for	a	Cl-	
secreting	epithelium,	combined	with	conflicting	reports	of	the	[Na+]i	(Amin,	Reza,	
Wang,	&	Leenen,	2009;	Johanson	&	Murphy,	1990;	Keep	et	al.,	1994;	Saito	&	Wright,	
1987;	Smith	&	Johanson,	1985;	Zeuthen,	1987).	Determining	the	direction	of	
NKCC1-	mediated	fluxes	is	critical	to	understanding	the	function	of	this	
cotransporter	in	CPECs.		If	NKCC1	works	in	the	net	efflux	mode,	it	may	be	involved	
in	CSF	secretion.	Conversely,	if	NKCC1	works	in	the	net	influx	mode,	as	it	does	in	the	
basolateral	membrane	of	other	chloride	secreting	epithelia,	then	it	would	have	an	
absorptive	function	in	CPECs	and	could	be	involved	in	cell	water	volume	(CWV)	
maintenance	and	CSF	K+	regulation.	
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Figure 1.1: Basic mechanisms for active Cl- secretion and absorption in Cl- transporting epithelia. Cl- secreting 
epithelia (A) have NKCC1 and NKATP on the basolateral membrane. K+ is recycled on the basolateral membrane through 
K+ channels, and Na+ is transported out through NKATP activity on the basolateral membrane.  NKCC1 maintains [Cl-]i 
above electrochemical equilibrium, and Cl- secretion occurs through apical Cl- channels. Cl- absorbing epithelia (B) have 
NKCC2 on the apical membrane and NKATP on the basolateral membrane. K+ is recycled on the apical membrane 
	 5	
through K+ channels, and Na+ is transported out through NKATP activity on the basolateral membrane.  Cl- efflux occurs 
through basolateral Cl- channels. CPECs (C) have NKCC1, NKATP, and Cl- and K+ channels on the apical membrane, 
which leads to the debate over the function of NKCC1 in these cells. 
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Importance	of	CSF	potassium	regulation	
	
Maintaining	a	low	CSF	[K+]	is	critical	for	normal	brain	function.	Under	normal	
conditions	the	CNS	[K+]	is	approximately	2.9	mM,	lower	than	the	plasma	[K+]	of	~4.7	
mM	(Damkier	et	al.,	2010;	Somjen,	2002).	The	CSF	[K+]	remains	constant	through	
the	combination	of	glia	and	CP	K+	absorption	(Bradbury	&	Kleeman,	1967;	Jones	&	
Keep,	1987;	Keep	&	Xiang,	1995;	Keep	et	al.,	1994;	Stummer,	Keep,	&	Betz,	1994).	
Glial	cells	utilize	NKCC1	to	absorb	K+	from	the	small	extracellular	spaces	around	
neurons	and	transport	it	away	to	either	the	blood	vessels	or	the	CSF	in	the	ventricles	
(Kahle	et	al.,	2009;	Lu	et	al.,	2006).		Once	K+	enters	into	the	CSF	filled	ventricles	(in	
these	experiments,	a	portion	of	the	CP	of	the	lateral	ventricles	was	isolated	using	an	
oil	filled	chamber.		A	small	amount	of	artificial	CSF,	with	varying	[K+],	was	added	to	
the	isolation	chamber	and	freshly	secreted	fluid	from	the	CP	was	collected	from	
under	the	oil	of	the	chamber.),	any	excess	is	removed	by	CPECs	(Ames,	Higashi,	&	
Nesbett,	1965;	Cserr,	1965;	Husted	&	Reed,	1976).	The	apical	membrane	of	CPECs	is	
considerably	more	permeable	to	K+	than	the	basolateral	membrane	(Keep	&	Xiang,	
1995;	Zeuthen	&	Wright,	1981),	and	CPECs	respond	to	a	rise	in	CSF	[K+]	by	
increasing	their	apical	K+	uptake	(Parmelee,	Bairamian,	&	Johanson,	1991).		Early	
studies	proposed	that	CPECs	regulate	the	[K+]	of	freshly	secreted	CSF	in	response	to	
the	[K+]	directly	around	them	(Ames	et	al.,	1965;	Husted	&	Reed,	1976).			CPECs	are	
very	responsive	to	high	CSF	[K+]	by	reducing	the	amount	[K+]	secreted,	however	
lowering	CSF	[K+]	elicits	only	a	slight	increase	in	the	[K+]	secreted	(Ames	et	al.,	
1965;	Husted	&	Reed,	1976).	Moreover,	CPECs	maintain	the	CSF	K+	homeostasis	
	 7	
even	with	severe	changes	in	plasma	[K+]:	CSF	[K+]	increases	only	~0.2	mM	when	
plasma	concentrations	of	K+	increased	up	to	9	mM,	and	CSF	[K+]	decreases	only	~0.5	
mM	when	plasma	[K+]	is	reduced	to	almost	2	mM	(Ames	et	al.,	1965;	Bekaert	&	
Demeester,	1954;	Cserr,	1965;	Husted	&	Reed,	1976).	Both	NKATP	and	NKCC1	can	
uptake	CSF	K+	on	the	apical	membrane	of	CPECs,	but	NKCC1	is	more	capable	of	CSF	
K+	sensing	and	regulation	because,	unlike	NKATP,	NKCC1	can	reverse	its	direction	of	
transport	under	physiological	conditions	(Russell,	2000).	The	low	CSF	[K+]	is	often	
attributed	to	the	presence	of	NKATP	on	the	apical	membrane	of	CPECs	(Redzic	&	
Segal,	2004).		The	NKATP	subunits	expressed	in	CPECs	are	α1b1	and	α1b2	that	have	
a	Km	for	K+	of	0.92	and	1.16	mM,	respectively	(Brown	et	al.,	2004;	Crambert	et	al.,	
2000;	Watts,	Sanchez-Watts,	Emanuel,	&	Levenson,	1991).		This	means	that	while	
NKATPα1b1/b2	has	a	high	affinity	for	[K+]o,	the	pump	is	working	close	to	maximal	
capacity,	or	Vmax	,	for	normal	external	[K+]	in	CPECs.		Additionally,	NKATP	alone	
cannot	account	for	the	K+-induced	cell	swelling	observed	in	glia	and	CPECs	since	the	
pump	does	not	transport	anions	(Macaulay	&	Zeuthen,	2012;	Wu,	Delpire,	Hebert,	&	
Strange,	1998).		In	comparison,	human	NKCC1	has	a	Km	for	external	K+	of	~2.7	mM	
(Payne	&	Forbush,	1995).	NKCC1’s	lower	affinity	and	higher	capacity	for	[K+]o	
bestows	the	cotransporter	with	the	ability	to	sense	and	respond	to	changes	in	CSF	
K+.		
NKCC1	
	
The	NKCC1	cotransporter	is	a	member	of	the	larger	Slc12a	cation-chloride	
	 8	
cotransporter	family	(Alvarez-Leefmans,	2012).	NKCC1	has	a	predicted	12-
transmembrane	domain	structure,	cotransports	Na+,	K+,	and	Cl-	ions	across	the	
plasma	membrane	with	a	stoichiometry	of	1Na+:	1K+:	2Cl-	,	and	is	inhibited	by	the	
loop-diuretic	bumetanide	(Alvarez-Leefmans,	2012;	Russell,	2000).	NKCC1	is	a	
secondary	active	transporter,	meaning	that	it	depends	indirectly	on	the	energy	
generated	from	ATP	by	using	the	sum	of	chemical	potential	gradients	of	2Cl-,	K+,	and	
Na+	that	is	established	by	NKATP	(Alvarez-Leefmans,	2012).	The	cotransport	of	two	
cations	(Na+	and	K+)	and	two	anions	(2x	Cl-)	per	cycle	is	electroneutral	and	coupled,	
thus	all	four	ions	must	first	bind	to	the	cotransporter	on	the	uptake	side	in	order	for	
NKCC1	to	transport	across	the	membrane	(Alvarez-Leefmans,	2012;	Lytle,	
McManus,	&	Haas,	1998).	NKCC1	is	ubiquitously	expressed	in	most	cell	types	and	
cotransports	both	ions	and	water	(Hamann,	Herrera-Perez,	Bundgaard,	Alvarez-
Leefmans,	&	Zeuthen,	2005;	Hamann	et	al.,	2010;	Macaulay	&	Zeuthen,	2012;	
Zeuthen	&	Macaulay,	2012).		
	
Activation	of	the	NKCC1	cotransporter	occurs	through	the	phosphorylation	
of	serine/threonine	residues	located	on	the	amino-terminal	(Gagnon,	England,	&	
Delpire,	2007).	The	cotransporter	is	phosphorylated	by	the	WNKs/SPAK/OSR1	
pathway:	WNKs	(with	no	lysine	(K)	kinases)	are	a	family	of	kinases	(WNK1-WNK4)	
activated	by	phosphorylation	in	response	to	osmotic	stress,	and	then	WNKs	
phosphorylate	and	activate	SPAK	(SPS1-related	proline/alanine-rich	kinase)	and	
OSR1	(oxidative	stress-response	kinase	1),	which	will	phosphorylate	and	activate	
NKCC1	(Delpire	&	Gagnon,	2006;	Gagnon,	England,	&	Delpire,	2006;	Grimm	et	al.,	
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2012;	Thastrup	et	al.,	2012).	Increased	phosphorylation	of	NKCC1	occurs	in	
response	to	a	drop	in	[Cl-]i	and	to	cell	shrinkage,	when	NKCC1-mediate	ion	and	
associated	water	fluxes	are	needed	to	maintain	cell	volume	and	[Cl-]i	(Alvarez-
Leefmans,	2012;	Delpire	&	Gagnon,	2006).	
Significance		
	
The	unusual	location	of	NKCC1,	together	with	NKATP,	on	the	apical	
membrane	of	CPECs	has	led	to	much	debate	about	the	function	of	the	cotransporter	
in	the	choroid	plexus,	including	its	role	in	cerebrospinal	fluid	secretion.		Uncertainty	
of	the	direction	of	NKCC1-mediated	activity	under	physiological	conditions	impedes	
our	understanding	of	CSF	secretion	and	our	ability	to	develop	effective	treatment	
strategies	to	control	conditions	such	as	brain	edema	and	hydrocephalus.		Both	
edema	and	hydrocephalus	can	occur	subsequent	to	brain	injury	(Unterberg,	Stover,	
Kress,	&	Kiening,	2004),	with	hydrocephalus	being	more	commonly	linked	with	
intracerebral	hemorrhages,	usually	resulting	from	a	blood	clot	in	a	weakened	artery,	
that	extend	into	the	ventricles	(Strahle	et	al.,	2012).		In	the	latter	example,	CSF	
drainage	is	usually	obstructed	by	swelling	in	the	cerebral	aqueduct,	or	at	the	
arachnoid	villi	or	granulations	(Strahle	et	al.,	2012).		As	the	pressure	of	CSF	
increases,	so	does	the	chance	of	cell	death	and	brain	damage	(Strahle	et	al.,	2012).	
Treatments	for	brain	edema	and	hydrocephalus	are	often	invasive,	such	as	inserting	
a	drainage	stent	or	performing	a	decompressive	craniectomy,	and	come	with	a	risk	
of	infection.	By	better	understanding	the	mechanisms	of	CSF	secretion	at	the	
choroid	plexus,	non-invasive	medications	can	be	developed	for	the	long-term	
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control	of	CSF	secretion.			
		 	
Whether	CPECs	utilize	NKCC1	for	CSF	secretion	is	unclear.	Blocking	NKCC1	
activity	in	the	choroid	plexus	by	intraventricular	application	of	bumetanide	results	
in	an	~50%	reduction	in	both	CSF	secretion	(Javaheri	&	Wagner,	1993)	and	apical	
Cl-	efflux	(Johanson,	Sweeney,	Parmelee,	&	Epstein,	1990),	as	well	as	an	~50%	
reduction	Na+,	K+,	and	Cl-	uptake	(Bairamian,	Johanson,	Parmelee,	&	Epstein,	1991;	
Johnson,	Singer,	S.,	Hoop,	B.,	Kazemi,	H.,	1987;	Preston,	Dyas,	&	Johanson,	1993).		
Bumetanide	also	causes	a	reduction	in	CPEC	water	volume	(Bairamian	et	al.,	1991;	
Wu	et	al.,	1998).		Equal	reduction	of	both	Cl-	influx	and	efflux	in	the	presence	of	
bumetanide	suggests	that	NKCC1-mediated	ion	and	associated	water	fluxes	in	
CPECs	are	inwardly	directed	under	basal	conditions	and	function	to	maintain	the	
cell	water	volume	required	for	CSF	secretion.		Additionally,	it	is	hypothesized	that	
NKCC1	is	working	near	to	its	flux	reversal	point	in	CPECs,	thus	permitting	the	
cotransporter	to	function	in	both	directions	(Keep	et	al.,	1994).		The	flux	reversal	
point,	or	chemical	equilibrium,	of	NKCC1	is	where	the	net	chemical	potential	free	
energy	driving	NKCC1	cotransport	(∆μNKCC1)	is	equal	to	zero,	given	by	the	following	
equation	1	for	this	electroneutral	cotransporter:	
	
(equation	1)	 	 	 ∆µ#$%%& = RT ∙ 	ln #.
/ 0∙ $/ 0∙ %12 03
#./ 4∙ $/ 4∙ %12 43
	,	
	
where	R	is	the	Gas	Constant	(8.314	Joules/	Kelvin/	mole)	and	T	is	temperature	in	
degrees	Kelvin.	Reported	values	for	the	intracellular	Na+	concentration	of	CPECs	has	
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varied	widely	over	the	past	few	decades,	and	it	is	impossible	to	calculate	the	flux	
reversal	point	for	NKCC1	without	knowing	this	concentration.	Measurements	using	
ion-selective	microelectrodes	in	amphibian	CPECs	report	a	[Na+]i	=10.5	mM	(Saito	&	
Wright,	1987),	in	contrast	to	mammalian	measurements,	using	ion	tracers	and	flame	
photometry,	that	asserted	that	CPECs	have	[Na+]i	as	high	as	48	mM	(Johanson	&	
Murphy,	1990).	It	should	be	noted	that	the	latter	measurement	technique	damages	
cells,	they	are	whole	tissue	measurements	of	total	ion	content	where	extra-	and	
intracellular	water	contents	are	subject	to	significant	errors,	usually	yielding	
erroneously	high	ion	concentrations.	Thus,	these	techniques	measure	total	Na+	(free	
plus	bound)	and	the	thermodynamically	relevant	parameter	is	the	free	Na+	ion	
(Harootunian,	Kao,	Eckert,	&	Tsien,	1989).	Most	animal	cells	have	a	low	[Na+]i	of	
approximately	10	mM	that	is	maintained	by	NKATP,	and	other	ion	cotransporters,	
including	NKCC1,	utilize	the	chemical	potential	energy	stored	in	the	Na+	gradient	
across	the	plasma	membrane	to	cotransport	ions	and	molecules	into	the	cell.		An	
[Na+]i	as	high	as	that	reported	by	Johanson	and	Murphey	(1990)	may	significantly	
alter	the	driving	force	of	cotransporters	on	CPECs.	Measurements	and	predictions	of	
high	[Na+]i	have	been	cited	as	evidence	to	support	NKCC1	working	in	the	outward	
direction,	however	the	validity	of	these	measurements	is	questionable	for	the	
reasons	given	above.		Having	a	clear	comprehension	of	the	biophysical	
characteristics	of	CPECs,	especially	ion	transport,	is	fundamental	to	the	knowledge	
of	CSF	secretion	and	homeostasis.		This	knowledge	is	key	to	develop	treatment	
strategies	in	which	the	control	of	CSF	production	or	its	regulation	is	needed,	such	as	
with	primary	or	secondary	intracranial	hypertension,	because	NKCC1	is	a	potential	
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pharmacological	target	for	controlling	CSF	secretion	(Kahle	et	al.,	2009;	Karimy	et	
al.,	2016;	Lu	et	al.,	2006).	
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Chapter	2:	General	Methods	
Animals	
	
NKCC1	-/-	mouse	breeders,	developed	from	C57/129	Swiss	mouse	strains	on	a	
mixed	background	(a	generous	gift	from	Dr.	Gary	Shull,	University	of	Cincinnati),	
were	used	to	develop	our	NKCC1	-/-	colony.	All	experiments	were	performed	with	
NKCC1	-/-	mice	derived	from	this	colony	or	their	WT	littermates.		The	Wright	State	
University	Laboratory	Animal	Care	and	Use	Committee	approved	the	housing,	
handling,	and	use	of	all	mice	in	accordance	with	National	Institutes	of	Health	
guidelines.	
In	every	experiment	in	which	NKCC1	-/-	mice	were	used,	the	animal’s	genotype	
and	phenotype	were	tested	to	ensure	that	it	was	a	homozygous	knockout.		NKCC1	-
/-	mice	have	slowed	growth	and	are	smaller	than	their	+/-	and	+/+	littermates,	they	
are	deaf,	and	they	display	shaker/	waltzer	behavior	that	manifests	as	the	mouse	
shaking	and	spinning	in	circles	(Delpire,	Lu,	England,	Dull,	&	Thorne,	1999;	Flagella	
et	al.,	1999).	An	NKCC1	-/-	mouse	had	to	display	these	three	phenotypes	to	be	used	
for	experiments.	The	imbalance	seen	in	NKCC1	-/-	mice	is	the	result	of	a	collapsed	
cochlear	duct	containing	a	K+-rich	endolymph	generated	by	NKCC1	(Delpire	et	al.,	
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1999;	Flagella	et	al.,	1999).	NKCC1	-/-	mice	also	have	reduced	blood	pressure,	
severely	impaired	saliva	production,	and	a	28%	incident	of	death	by	weaning	at	
postnatal	age	(P)	21	days	(Evans	et	al.,	2000;	Flagella	et	al.,	1999).	Due	to	the	latter	
phenotypes,	all	NKCC1	-/-	mice	were	euthanized	at	P21,	if	they	were	not	used	for	an	
experiment.		
Genotyping	
	
The	procedure	used	to	genotype	NKCC1	-/-	mice	was	performed	using	1	–3	mm	
of	tissue	obtained	from	mouse-tail	clips	performed	during	postnatal	days	3	–6.		Tail	
clips	were	processed	and	the	DNA	extracted	using	Qiagen	DNeasy	Blood	and	Tissue	
Kit	for	Spin-columns.		Polymerase	chain	reaction	(PCR)	amplification	was	
performed	in	21	µL	and	containing:		13.4	µL	ultra-pure	water,	0.4	µL	Taq	DNA	
Polymerase	(GenScript),	4	µL	10x	Taq	Buffer	(Invitrogen),	1	µL	dNTP	(10	µM,	
USB/Affimetrix),	1.2	µL	mouse	NKCC1	(mNKCC1)	custom	primers	(see	Table	2.1,	
Integrated	DNA	Technologies),	and	0.5	µL	mouse	DNA.		The	PCR	reaction	was	
performed	using	a	thermocycler	(BioRad)	under	the	following	protocol:		4	min	95°	
C;	34	cycles	(30	sec	95°	C,	30	sec	60°	C,	50	sec	72°	C);	10	min	72°	C;	hold	at	0°	C.		
PCR	products	weights	were	separated	using	a	gel	electrophoresis	bath	in	a	2%	
agarose	gel.		
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Table	2.1:	mNKCC1	custom	PCR	Primers	
Primer Sequence 
mNKCC1	5’	 G	G	A	A	C	A	T	T	C	C	A	T	A	C	T	T	A	T	G	A	T	A	G	A	T	G	
mNKCC1	3’	 C	T	C	A	C	C	T	T	T	G	C	T	T	C	C	C	A	C	T	C	C	A	T	T	C	C	
mNKCC1	neo	 G	A	C	A	A	T	A	G	C	A	G	G	C	A	T	G	C	T	G	G	
	
Lists	the	custom	mNKCC1	primers	used	for	genotyping	NKCC1	-/-	mice.	
	
Isolation	of	single	CPECs		
	
Mice,	P10-P21,	were	anesthetized	using	CO2	then	euthanized	by	rapid	
decapitation.		As	detailed	in	Figure	2.1,	the	brain	was	removed	and	immediately	
submersed	into	room	temperature	Dulbecco’s	Phosphate	Buffered	Saline	(DPBS,	
Life	Technologies,	no	Ca2+	&	no	Mg2+),	pH	7.1,	and	the	CP	of	the	fourth	ventricle	was	
visualized	and	dissected-out	under	a	20X	microscope.		The	dissected	CP	was	
incubated	for	1	hour	in	1	mL	of	dissociation	media	that	was	composed	of	culture	
media	supplemented	with	protease	XIV	(0.5	mg/	mL,	Sigma	Aldrich)	and	
collagenase	IV	(0.5	mg/	mL,	Sigma	Aldrich).		Culture	media	was	prepared	the	day	of	
the	experiment,	and	the	following	ingredients	were	brought	to	room	temperature,	
combined	into,	and	pass	through	a	10	mL	lauer-lock	syringe	attached	to	a	sterile	
filter	(33	mm	Millex	-GP	Express	PES	0.22	µm,	Merck	Millipore)	before	use:	DMEM/	
F12	(HyClone-Fisher),	10%	heat-inactivated	FBS	(Gibco-Fisher),	penicillin/	
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streptavidin	(HyClone-Fisher,	10	U/	mL:	10	µg/	mL),	and	hEGF	(40	ng/	mL).		
Following	the	incubation,	the	dissociation	media	was	aspirated	off	and	the	CP	was	
rinsed	3X	with	culture	media	before	the	final	volume	of	500	µL	of	culture	media	was	
added.		To	dissociate	the	cells,	the	CP	in	culture	media	was	vigorously	shaken	with	a	
vortex	shaker	for	3	seconds,	after	which	the	cells	were	gently	triturated	with	fire-
polished	glass	Pasteur	pipettes	of	two	different	bore	diameters	that	were	equivalent	
to	23	and	32	gauge	needles	(used	in	that	order),	20X	per	bore	size.		Cells	were	
plated	on	laminin	(Sigma	Aldrich,	No.	L-2020,	5	µg	/ml)	and	poly-D-lysine	(BD	
Bioscience,	No.	354210,	100	µg	/ml)	coated	25-mm	sterile	and	de-greased	cover	
slips	(Electron	Microscopy	Sciences,	No.	72196-25).	Degreased	cover	slips	were	
soaked	for	24-72	hours	in	acetone	(Fisher)	then	rinsed	3x	first	in	70%	ethanol	
(Fisher,	diluted	with	double	distilled	water	(ddH2O))	followed	by	a	3x	rinse	in	
ddH2O	prior	to	being	sterilized	to	remove	any	manufacturing	residues.		Plated	cells	
were	incubated	at	5%	CO2	–95%	air	atmosphere	/85	–95%	humidity	/37°	C	for	2	–6	
hours	prior	to	use	for	experimentation.		
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Figure 2.1: Dissection of the CP of the 4th ventricle in mouse. The dissected 
mouse brain was immediately submerged into a silicone lined dissection plate 
that contained sterile room temperature DPBS.  Two 23 gauge needles were 
used to secure the brain ventral-side-up in the silicone at the points marked with 
X.  The tissue was illuminated and visualized under a 20X dissection microscope.  
A pair of #4 micro-forceps was used to gently pick-up the brain stem (at point A) 
and fold it upwards so that the ventral surface of the brain was in contact with the 
ventral surface of the brain stem (B).  The CP (D) was located by following the 
dorsal mid-line (C) in the posterior direction towards the cerebellum.  The CP of 
the 4th ventricle is Y-shaped, and, with a second pair of #4 forceps, each “arm” of 
the CP was first freed from the connective tissue and vasculature before the 
entire CP was dissected-out in one piece. 
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Saline	Solutions	
HEPES-buffered	solutions	
	
The	isosmotic	(ISO)	physiological	control	solution,	herein	referred	to	as	
artificial	CSF	(aCSF),	contained	123.5	mM	NaCl,	3	mM	KCl,	1	mM	CaCl2,	1.25	mM	
MgCl2,	5	mM	HEPES,	and	10	mM	glucose.		The	pH	adjusted	to	7.3	at	25°	C	with	1	M	
NaOH,	and	the	osmolality	adjusted	to	290	±	1%	mOsm	with	sucrose.		Isosmotic	
nominally	chloride	free	(0Cl)	and	isosmotic	nominally	sodium	free	(0Na)	solutions	
were	made	by	mole-for-mole	replacement	of	Cl-	with	gluconate	and	Na+	with	NMDG	
(N-methyl-D-glucamine)	+	HCl,	respectively.		Solutions	with	various	[K+]o	were	
made	by	adding	the	corresponding	volume	of	3	M	KCl	prior	to	adjusting	the	
osmolality	with	sucrose.		Osmotic	calibration	solutions	were	created	by	adjusting	
the	amount	of	sucrose	in	the	ISO	to	261	±	1%	mOsm	for	the	10%	hyposmotic	
solution	and	319	±	1%	mOsm	for	the	10%	hyperosmotic	solution.		The	osmolality	of	
all	solutions	was	measured	with	a	Wescor	osmometer.	
Bicarbonate-buffered	solutions	
	
Bicarbonate	buffered	aCSF	solutions	contained	105.2	mM	NaCl,	2	mM	
NaH2PO4,	1	mM	CaCl2,	1.25	mM	MgCl2,	3	mM	KCl,	10.5	mM	Glucose,	and	24.8	mM	
NaHCO3.		The	pH	adjusted	to	7.3	by	slowly	adding	the	NaHCO3	after	the	solution	has	
been	bubbled	for	20	min	with	5%	CO2	balanced	with	air,	and	the	osmolality	adjusted	
to	290	±	1%	mOsm	with	sucrose.		Osmotic	calibration	solutions	and	isosmotic	
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solutions	with	variations	in	[K+]o	were	made	in	the	same	manner	as	with	the	HEPES	
buffered	solutions.	
Drug	and	Chemical	Preparation	
	
Stock	solutions	of	chemicals	were	prepared	using	dimethyl	sulfoxide	(DMSO)	or	
water	as	the	initial	solvent,	and	then	diluted	using	aCSF.		When	DMSO	was	used	as	
the	solvent,	care	was	taken	to	ensure	that	the	final	amount	of	total	DMSO	in	the	
solution	was	less	than	1%.		This	preparation	was	used	for	Bumetanide,	Ouabain,	
Verapamil,	Calcein-AM,	Asante	Natrium	Green-2	(ANG-2),	and	N-
(Ethoxycarbonylmethyl)-6-Methoxyquinolinium	Bromide	(MQAE).		
Fluorescence	imaging	microscopy		
	
Cover	slips	with	attached	CPECs	were	mounted	into	a	fluid	perfusion	imaging	
chamber	(~300	µL	volume)	that	rested	on	the	stage	of	an	epifluorescence	inverted	
microscope	(Olympus	IX-81,	Olympus	America,	Center	Valley,	PA)	equipped	with	an	
oil-immersion	lens	(Olympus,	40X,	NA	1.35)	and	differential	interference	contrast	
(DIC)	optics	(Figure	2.2).		Physiological	solutions	were	perfused	over	the	cells	at	a	
rate	of	6	mL/	min	at	25°	C,	and	changes	in	fluorescence	intensity	of	individual	cells	
were	measured	through	a	digital	pinhole	(15	x	15	pixels	for	calcein	and	MQAE,	and	
20	x	20	pixels	for	ANG-2)	using	MetaSeries	Software	(Alvarez-Leefmans,	Herrera-
Perez,	Marquez,	&	Blanco,	2006).		Light	originating	from	a	xenon	arc	lamp	was	
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directed	through	the	input	slit	of	a	monochromator	(Optoscan,	Cairn	Research	
Limited,	UK)	that	allowed	independent	control	of	both	the	wavelength	of	light	and	
the	output	slit	width	of	the	beam	of	light	emitted.	The	light	beam	then	passed	
through	a	liquid	guide	and	neutral	density	filter	to	reduce	photodynamic	damage	
and	photo-bleaching	prior	to	entering	the	optical	path	of	the	microscope.		To	use	
Calcein	as	an	example,	the	excitation	wavelength	for	calcein	is	495	±	3	nm	and	the	
peak	emission	occurs	at	535	nm,	thus	a	515	nm	dichroic	mirror/	535	emissions	
filter	cube	(Chroma	Technology)	was	used	to	reflect	excitation	wavelengths	below	
515	nm	into	the	inverted	objective	where	it	excited	the	fluorophores	within	the	
cells.	Any	wavelengths	above	515	nm,	calcein	emissions,	were	able	to	pass	back	
down	through	the	dichroic	mirror	and	reached	the	535	nm	emissions	filter	below.		
The	emission	filter	prevented	stray	light,	outside	the	emission	filter	wavelength	of	
535	±	13	nm,	from	reaching	the	cooled	CCD	camera	(Hamamatsu	ORCA-ER	C4742-
95).	To	further	reduce	photodynamic	damage	to	CPECs,	the	shutter	speed	was	kept	
between	40	–80	ms	and	fluorescence	acquisition	frequency	was	0.1	–0.25	Hz.		
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Figure 2.2: Microscope set-up for quantitative fluorescence imaging microscopy. Imaging setup used to record 
CWV changes and/or intracellular Na+ and Cl- in single CPECs loaded with calcein or ion-indicator. The filter’s 
wavelengths are shown for Calcein.  This figure is modified from Alvarez-Leefmans, F. J., Herrera-Perez, J. J., Marquez, 
M. S., & Blanco, V. M. (2006). Simultaneous measurement of water volume and pH in single cells using BCECF and 
fluorescence imaging microscopy. Biophysical Journal, 90(2), 608-618, and is reproduced with permission. 
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Figure 2.3: Basic principles and methods for measuring changes in CWV. NKCC1-mediated ion transport is tightly 
linked to water transport (Hamann et al., 2010), thus the direction and relative magnitude of NKCC1-mediated fluxes can 
be inferred by measuring changes in relative CWV in single CPECs. A) from Alvarez-Leefmans, F.J. (unpublished), 
reproduced with permission.  Two models explaining how NKCC1-mediated ion transport is tightly linked to water 
transport. B) This figure is modified from Alvarez-Leefmans et al., (2006). Simultaneous measurement of water volume 
and pH in single cells using BCECF and fluorescence imaging microscopy. Biophysical Journal, 90(2), 608 -618.  Basic 
principle for measuring relative CWV through a pinhole in CPECs using live-cell imaging fluorescence microscopy in 
dissociated CPECs loaded with the fluorescent probe calcein (Alvarez-Leefmans et al., 2006), and reproduced with 
permission. 
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Measurement	of	cross-sectional	area	of	in	vitro	CPECs	
	
Using	the	microscope	set-up	described	above,	freshly	dissociated	CPECs	from	
WT	and	NKCC1	KO	mice	were	visualized	and	imaged	using	differential	interference	
contrast	(DIC)	microscopy.	The	perimeter	of	each	living	cell	imaged	with	DIC	was	
digitally	outlined	offline	using	a	mouse,	and	cross-sectional	areas	of	individual	cells	
calculated	using	MATLAB	(Math	Works),	using	algorithms	developed	by	Mr.	Aaron	
Madaris.	Cells	were	loaded	with	Calcein-AM,	which	was	used	for	subsequent	parts	of	
the	experiments	to	measure	CWV	changes,	but	also	indicated	cell	viability.	Only	cells	
that	were	loaded	with	Calcein	were	measured	using	DIC	imaging.	Each	cell	within	
the	field	was	identified	with	a	color-coded	pinhole	and	a	number.	
Method	to	measure	cell	water	volume	changes	in	single	CPECs	
	
NKCC1-mediated	ion	fluxes	are	tightly	linked	to	water	fluxes	that	occur	
either	through	the	cotransporter	or	through	aquaporins	(Figure	2.3A)	(Alvarez-
Leefmans,	2012;	Hamann	et	al.,	2005;	Hamann	et	al.,	2010;	Macaulay	&	Zeuthen,	
2012).		Therefore,	changes	in	cell	volume	can	be	measured	as	a	surrogate	for	
NKCC1-mediated	fluxes	(Alvarez-Leefmans	et	al.,	2006;	Hamann	et	al.,	2010).		
Changes	in	the	fluorescence	intensity	of	intracellular	free	Calcein	are	inversely	
proportional	to	changes	in	cell	water	volume	(Figure	2.3B),	according	to	the	
following	equation	2	from	Alvarez-Leefmans	et	al.,	(2006):	
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(equation	2)		 	 	 	 CWV =	&'
('
,	
	
where	CWV	is	relative	cell	water	volume,	Qm	is	total	intracellular	content	of	the	dye	
(m),	and	Cm	is	the	relative	change	in	concentration	of	m.	CWV	can	be	determined	by	
measuring	changes	in	Calcein	fluorescence	(Cm)	as	long	as	Qm	is	constant	(Alvarez-
Leefmans	et	al.,	2006).		Calcein	was	loaded	by	exposing	the	cells	to	a	solution	
containing	of	2	μM	of	Calcein-AM	(Invitrogen)	along	with	20	μM	Verapamil	
(Invitrogen).	Verapamil	was	added	to	inhibit	the	multi-drug	resistant	P-glycoprotein	
that	is	expressed	in	CPECs	and	can	remove	fluorescent	dyes	from	the	cell	(Rao	et	al.,	
1999	Snyder,	Finch,	Sartorelli,	Piwnica-Worms,	1999;	Robertson,	1995;	Valverde	et	
al.,	1996).		Calcein	was	excited	at	495	±	3	nm	for	80	ms	at	a	frequency	of	0.25	Hz	and	
the	emission	recorded	above	515	nm.			Volume	calibration	was	performed	for	each	
cell	with	±	10%	anisosmotic	solutions.		
	
Data	analysis	was	performed	using	SigmaPlot	versions	9	&	12,	and	Microsoft	
Excel.		When	required,	drift	correction	of	the	Calcein	transient	was	performed	using	
a	linear	regression.		Calcein	fluorescence	was	converted	to	CWV	using	the	following	
equation	3	(Alvarez-Leefmans,	1995):	
	
(equation	3)		 		 	 	 *+
*,
= 	
(
.+
.,
/	0123456,789)
(;/	0123456,789)
	,	
	
where	Vt	is	cell	water	volume	with	respect	to	time	of	the	entire	transient,	Vo	is	Vt	at	t	
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=	0,	Ft	is	the	measured	fluorescence	intensity	with	respect	to	time,	Fo	is	the	steady-
state	fluorescence	intensity	at	baseline	(during	ISO),	and	FBackground	is	the	
background	fluorescence	of	the	cell	that	is	insensitive	to	changes	in	CWV.				
Measurement	of	intracellular	chloride	in	single	CPECs	
	
The	[Cl-]i	of	CPECs	was	measured	using	the	fluorescent	indicator	MQAE	(N-
(Ethoxycarbonylmethyl)-6-Methoxyquinolinium	Bromide,	Invitrogen).		MQAE	is	a	
single	wavelength	indicator	that	detects	Cl-	through	collisional	quenching	(Verkman,	
Sellers,	Chao,	Leung,	&	Ketcham,	1989).		The	method	for	measuring	[Cl-]i	in	CPECs	
follows	the	procedure	used	in	other	cell	types	(Mao	et	al.,	2012;	Rocha-Gonzalez,	
Mao,	&	Alvarez-Leefmans,	2008).		MQAE	was	applied	to	the	chamber	containing	
CPECs	at	a	concentration	of	5	mM	and	with	20	μM	Verapamil.		The	dye	was	excited	
at	350	±	5	nm	for	20	ms	at	a	frequency	of	0.1	Hz;	the	peak	emission	wavelength	was	
460	nm	captured	every	10	seconds.		CPECs	were	equilibrated	in	isosmotic	aCSF	
prior	to	Cl-	depletion	by	exposing	the	cells	to	an	isosmotic	0Cl	solution.	Once	a	new	
steady	state	was	reached	in	the	0Cl	solution,	the	CPECs	were	considered	fully	
depleted	of	intracellular	Cl-,	and	external	Cl-	was	replaced	with	isosmotic	aCSF.		At	
the	end	of	the	experiment	MQAE	was	calibrated	against	[Cl-]i	using	the	double	
ionophore	technique	(Koncz	&	Daugirdas,	1994;	Krapf,	Berry,	&	Verkman,	1988;	
Mao	et	al.,	2012;	Rocha-Gonzalez	et	al.,	2008).	CPECs	were	permeabilized	with	the	
K+/H+	ionophore	Nigericin	(5	μM,	Sigma	Aldrich)	and	the	Cl-/	OH-	ionophore	
Tributyltin	Acetate	(10	μM,	Sigma	Aldrich).		Calibration	solutions	contained	10	mM	
Glucose,	5	mM	HEPES,	120	mM	K+,	and	[Cl-]	+	[NO3-]	=	120	mM.		The	calibration	
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steps	were	0,	20,	40,	and	60	mM	Cl-	and	then	MQAE	was	quenched	with	a	final	
solution	of	150	mM	KSCN	to	set	the	background.			
	
MQAE	signal	drift	correction	was	performed	offline	by	fitting	the	entire	data	
transient	to	a	straight	line	(Mao	et	al.,	2012;	Rocha-Gonzalez	et	al.,	2008).	The	
correlation	coefficient	of	the	fit	was	³	0.99	for	the	cell	to	be	included	in	the	analysis.			
MQAE	fluorescence	data	was	then	converted	to	[Cl-]	using	the	Stern-Volmer	
equation:	
	
(equation	4)	 	 	 	 [Cl/]? = 	
((
.,
.+
)/;)
@AB
	
		
where	Fo	=	the	steady-state	fluorescence	during	chloride	depletion	using	the	0Cl	
solution,	Ft	=	fluorescence	measurements	with	respect	to	time,	and	Ksv	=	Stern-
Volmer	Constant.		Ksv	was	obtained	by	plotting	the	mean	fluorescence	
measurements	of	the	calibration	steps	to	the	Stern-Volmer	Graph	(Fo/Ft)	–1	vs.	[Cl-]	
and	taking	the	slope	as	Ksv.		The	mean	Ksv	for	the	intracellular	calibration	of	MQAE	in	
WT	CPECs	was	within	the	normal	range	at	17.0	±	0.6	M-1	(mean		±		SEM,	n	=	5	
animals)	and	the	mean	KSV	of	KO	CPECs	was	10.4	±	1.2	M-1	(n	=	7	animals).	In	other	
cell	types	the	reported	values	for	intracellular	Ksv	is	5	–25	M-1	(Kaneko,	Putzier,	
Frings,	Kaupp,	&	Gensch,	2004;	Mao	et	al.,	2012).		Further,	the	MQAE	analysis	
followed	three	constraints	described	in	Mao	et	al.,	2012.		Briefly,	for	a	cell	to	be	
included	in	the	analysis	1)	the	correlation	coefficient	for	the	line	fitting	the	
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calibration	plot	³	0.99,	2)	MQAE	fluorescence	in	each	calibration	solution	reached	
steady	state,	and	3)	MQAE	fluorescence	in	the	both	the	isosmotic	aCSF	and	0Cl	
solutions	reached	steady	state	(Mao	et	al.,	2012).		The	Cl-	equilibrium	potential	(ECl)	
was	calculated	from	the	Nernst	equation:	
	
(equation	5)	 	 	 	 E(D = 	
EF
G0
ln
[(DI]J
[(DI],
	
	
where	z	(=	-1)	is	the	valence	of	Cl-,	R	is	the	gas	constant,	T	is	temperature,	and	F	is	
the	Faraday	constant.	
Measurement	of	intracellular	sodium	in	single	CPECs	
	
	Measurements	of	[Na+]i	were	done	with	the	fluorescent	sodium	indicator	
dye	Asante	Natrium	Green	2	(ANG-2)	(TEFLabs,	2012).		CPEC	[Na+]i	measurements	
were	first	attempted	with	SBFI,	but	the	cells	could	not	be	successfully	loaded	with	
the	indicator.	ANG-2	has	a	similar	Na+	binding	affinity	as	SBFI,	and	was	developed	as	
an	alternative	Na+	indicator	(Lamy	&	Chatton,	2011;	Roder	&	Hille,	2014).		Unlike	
SBFI,	ANG-2	is	a	single	wavelength	dye	with	excitation	and	emission	wavelengths	at	
488	–517	nm	(peak	excitation	at	517	nm)	and	540	nm,	respectively	(Lamy	&	
Chatton,	2011;	TEFLabs,	2012).		The	benefit	of	ANG-2	is	that	it	is	easier	to	load	into	
cells	and	the	excitation	wavelength	is	less	damaging	compared	to	the	near	
ultraviolet	excitation	wavelengths	of	SBFI.		ANG-2	was	applied	to	the	cover	slip	at	
concentration	5	μM,	along	with	an	equal	volume	of	the	nonionic	detergent	Pluronic	
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F-127	(20%	weight/	volume)	and	verapamil	(20	μM).		During	the	data	acquisition	
the	excitation	wavelength	was	set	at	500	±	10	nm	for	80	ms	at	a	frequency	of	0.1	Hz.	
The	fluorescence	intensity	of	each	cell	was	sampled	every	10	seconds	until	a	steady-
state	was	achieved,	and	then	calibration	of	the	dye	was	done	at	the	end	of	each	
experiment	to	determine	[Na+]i.		At	the	start	of	calibration	cells	were	treated	with	a	
nonselective	monovalent	cation	ionophore,	Gramicidin	D	(7	μM,	Sigma	Aldrich),	to	
collapse	the	Na+	and	K+	gradients	across	the	cell	membrane	(Robertson,	1995).		
Calibration	solutions	contained	10	mM	HEPES,	1.2	mM	Ca2+,	57.4	mM	Cl-,	65	mM	
gluconic	acid,	with	[Na+]	+	[K+]	=	120	mM,	pH=	7.3,	and	290	mOsm,	adjusted	with	
sucrose.		The	calibration	points	were	120,	90,	60,	30,	12,	and	6	mM	Na+.			
	
To	analyze	the	fluorescence	measurements,	the	data	transient	was	first	
normalized	to	the	0Na	calibration	steady-state	measurements	using	the	equation	6:	
	
(equation	6)	 	 	 	 	1-Fo/Ft,		
	
where	Fo	=	mean	fluorescence	measurements	during	the	0Na	calibration	at	steady-
state,	Ft	=	the	fluorescence	measurements	with	respect	to	time	of	the	entire	
transient,	and	it	was	subtracted	from	1	so	that	the	data	was	not	inverted.		The	mean	
measurement	for	each	Na+	Calibration	solution	was	then	used	to	plot	the	graph	1-
Fo/Ft	vs.	[Na+]	(mM).		From	this	graph,	a	regression	curve	was	fitted	using	the	
Michaelis-Menton	equation,		
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(equation	7)	 	 	 	 y = 	 (0'2L∙[NO
P])
(@9Q[NO
P])
	
	
and	a	report	was	created	giving	the	Fmax	and	Kd	values	for	each	individual	cell.		The	
normalized	data	(1-Fo/Ft)	was	then	converted	into	[Na+]	using	the	following	
equation	8	that	was	based	on	the	Ca2+	indicator	FURA-2	and	modified	here	for	ANG-
2	(Grynkiewicz,	Poenie,	&	Tsien,	1985):		
	
(equation	8)	 	 	 NaQ = 	KU ∙ 	
(0/	0'J8)
(0'2L/	0)
	
	
Where	F	=	the	normalized	data	1-Fo/Ft,	Fmin	=	0,	Fmax	and	Kd	were	taken	from	the	
report.	
Method	for	immunofluorescence	labeling	of	NKATPa1	and	aquaporin	1	
(AQP1)	
	
Brain	and	kidney	tissues	of	WT	and	NKCC1	KO	mice,	P17-19,	were	used	to	
verify	the	polarized	expression	of	NKATP	and	AQP1	in	the	CPECs	NKCC1	KO	mice.	
After	animal	fixation,	tissue	was	post-fixed	using	4%	Paraformaldehyde	for	1	-2	
hours	prior	to	cryoprotecting	in	15%	sucrose.		Cryostat	sectioning	of	tissue	(10	μm)	
was	mounted	directly	onto	slides	to	protect	the	CP.			
	
AQP1:		Sections	were	permeabilized	using	0.1%	Triton-X	and	blocked	for	30	
minutes	with	10%	goat	serum	before	overnight	incubation	in	a	humidity	chamber	at	
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4°	C	using	rabbit	polyclonal	antibody	against	rat	AQP1	(5	μg/	mL,	Alpha	
Diagnostics).		The	sections	were	washed	3x	5	min	in	0.01	M	PBS	both	before	and	
after	a	1.5-hour	incubation	with	goat	anti-rabbit	Alexa	594	(1:200,	Jackson	
ImmunoResearch).		The	coverslip	was	mounted	using	ProLong	Gold	Anti-fade	
reagent	with	DAPI	(Invitrogen).	
	
NKATPa1:		Tissue	was	stained	using	Vector	Mouse	on	Mouse	(M.O.M.)	
Antibody	Kit.		Briefly,	sections	were	permeabilized	in	ice-cold	acetone	at	-20°	C	for	
5-10	minutes	and	were	allowed	to	air	dry.		Sections	were	washed	2x	2	minute	in	
0.01M	PBS	prior	to	the	application	of	each	solution.		To	start,	there	was	a	1-hour	
incubation	in	M.O.M.	Mouse	Ig	Blocking	Reagent	solution.		The	sections	were	then	
incubated	for	30	minutes	in	M.O.M.	Diluent	solution	that	contained	the	mouse	
monoclonal	NKATP-α1	subunit	antibody	(4	μg/ml,	Millipore),	followed	by	a	10-
minute	incubation	in	M.O.M.	Biotinylated	Anti-Mouse	IgG	Reagent	solution,	and	a	5-
min	incubation	in	Fluorescein	Avidin	DCS	solution.		Sections	received	a	final	3x	3	
minute	PBS	wash	before	they	were	mounted	on	coverslips	with	either	ProLong	Gold	
w/	DAPI	or	VectaShield	Anti-Fade	Reagent.	
Statistics	
	
Data	is	presented	as	the	mean	±	standard	error	of	the	mean	(SEM),	n	=	
number	of	animals.		Individual	animal	means	were	calculated	by	taking	the	mean	of	
the	cells	obtained	from	that	animal,	then	those	means	were	averaged	and	the	SEM	
calculated	using	Microsoft	Excel.		Comparison	of	ion	concentrations	between	CPECs	
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from	WT	and	NKCC1	KO	was	performed	using	an	unpaired	Student’s	t-test	for	
independent	samples	in	Sigma	Plot	version	9.	
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Chapter	3:	Specific	Aims	
	
The	overall	objective	this	research	is	to	understand	how	CPECs	secrete	CSF	
and	regulate	its	ionic	composition	in	order	to	find	safe	and	more	effective	treatment	
strategies	to	control	CSF	secretion,	The	Central	Thesis:	NKCC1	functions	as	a	
sensor	and	regulator	of	CSF	[K+]	in	the	apical	membrane	of	CPECs	by	working	near	
to	its	flux	reversal	point	and	in	the	inward	direction	under	basal	physiological	
conditions.	The	Km	for	external	K+	and	the	thermodynamic	features	of	NKCC1	
enables	it	to	reverse	net	flux	direction	in	response	to	small	(±	2	mM)	changes	in	
external	[K+].	To	prove	this	thesis	the	two	following	aims	have	been	developed:	
		
1)	Determine	the	direction	NKCC1-mediated	ion	and	associated	water	net	
fluxes	in	CPECs	under	basal	conditions.		Hypothesis:	A	function	of	NKCC1	in	
CPECs	is	maintenance	of	both	normal	and	constant	cell	water	volume.	Under	basal	
physiological	conditions	NKCC1	is	constitutively	active,	inwardly	transporting	ions	
and	associated	water.	Epithelial	cell	volume	maintenance	requires	equal	rates	of	
solute	and	water	entry	and	exit	across	the	apical	and	basolateral	membranes,	
respectively	(Ruess,	1988).	Hence,	we	predict	that	NKCC1	inactivation	results	in	
CPEC	shrinkage	due	to	unbalanced	solute	and	water	fluxes.	
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The	direction	of	NKCC1	activity	can	be	inferred	by	measuring	cell	water	
volume	in	the	presence	and	absence	of	NKCC1	transport	activity.	NKCC1	activity	is	
inhibited	in	this	research	using	a	three-pronged	approach	that	includes	
pharmacological	inhibition	of	the	cotransporter,	genetic	ablation	of	the	NKCC1	
protein,	and	ion-substitution	experiments.		Pharmacological	inhibition	of	NKCC1	is	
performed	using	the	loop-diuretic	bumetanide	and	genetic	ablation	via	the	global	
NKCC1	knockout	(KO)	mouse.	Using	these	approaches	controls	for	any	unknown	
variables,	such	as	a	compensatory	mechanism,	that	may	be	present	with	the	NKCC1	
global	KO	mouse	model	(Eisener-Dorman,	Lawrence,	&	Bolivar,	2009;	Nelson,	
1997).		Additionally,	the	extracellular	ion	dependence	of	changes	in	CWV	is	
examined	to	determine	whether	the	apical	location	of	NKCC1	impacts	the	function	
of	this	cotransporter	as	a	Cl-	loader,	given	that	the	CP	is	considered	a	Cl-	secretory	
epithelium.			
	
2)	Test	the	hypothesis	that	NKCC1	functions	as	a	sensor	and	regulator	of	CSF	
[K+]	in	CPECs.	Hypothesis:		NKCC1	is	working	near	to	its	chemical	equilibrium	in	
CPECs,	therefore	small	changes	in	[K+]o	are	sufficient	to	alter	both	the	direction	and	
magnitude	of	NKCC1-mediated	ion	and	associated	water	fluxes.	
	
Experiments	will	test	the	sensitivity	of	NKCC1	to	small	changes	in	[K+]o	in	
CPECs	by	comparing	the	responses	of	cells	from	NKCC1	KOs	to	those	from	WT	mice.	
The	flux	reversal	point	of	NKCC1	in	CPECs	is	calculated	by	modeling	the	net	free	
energy	driving	NKCC1	cotransport	with	respect	to	[K+]o.	Our	model	predicts	that	
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apical	NKCC1	is	working	in	the	net	inward	mode	under	basal	conditions,	and	near	to	
chemical	equilibrium,	i.e.,	its	flux	reversal	point.	Consequently,	CPECs	can	utilize	
NKCC1	to	sense	and	control	the	K+	uptake	and/or	secretion	in	response	to	the	
[K+]CSF.	
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Chapter	4:	Specific	Aim	1	Results	
	
Testing	the	hypothesis	of	Specific	Aim	1	requires	that	the	following	questions	
be	answered:	
1) What	is	the	direction	of	NKCC1-mediated	fluxes	in	CPECs	under	
physiological	conditions?	
2) Is	NKCC1	constitutively	active	and	functioning	to	maintain	normal	and	
constant	cell	water	volume	in	CPECs?	
Knowing	the	direction	of	NKCC1-mediated	fluxes	under	basal	physiological	
conditions	is	critical	to	understanding	how	this	cotransporter	functions	on	the	
apical	membrane	of	CPECs,	and	whether	NKCC1	contributes	to	CSF	secretion	
directly	vs	indirectly.	If	NKCC1	is	constitutively	active	and	functions	in	the	
maintenance	of	CPEC	water	volume,	then	NKCC1-mediated	fluxes	contribute	
indirectly	to	CSF	secretion,	as	opposed	to	a	direct	contribution	to	CSF	secretion	via	
ion	efflux.	Given	that	NKCC1	is	phosphorylated	and	activated	in	response	to	cell	
shrinkage	or	a	decrease	in	[Cl-]i,	we	predict	that	in	CPECs	the	NKCC1-mediated	
fluxes	are	inwardly	directed	under	basal	physiological	conditions,	and	indirectly	
contribute	to	CSF	secretion	by	maintaining	both	normal	and	constant	cell	water	
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volume	needed	for	sustained	activation	of	volume-sensitive	transporters	and	
channels.		
Morphometric	comparison	of	the	cross-sectional	areas	of	CPECs	from	
NKCC1	KO	and	WT	mice	
	
Cell	water	volume	is	maintained	by	balancing	the	net	influx	and	the	net	efflux	
of	solute	and	water	across	the	plasma	membrane.		Removing	NKCC1-mediated	ion	
fluxes	will	unbalance	the	net	trans-epithelial	solute	and	water	fluxes	and	reveal	the	
direction	of	cotransport	(Figure	4.1),	because	epithelial	cell	volume	maintenance	
requires	equal	rates	of	solute	and	water	influx	and	efflux	across	the	apical	and	
basolateral	membranes	(Ruess,	1988).		CPECs	are	reported	to	shrink	when	NKCC1	is	
blocked	with	bumetanide,	suggesting	that	the	cotransporter	is	constitutively	active	
and	inwardly	directed	in	these	cells	(Bairamian	et	al.,	1991;	Wu	et	al.,	1998).	
Bairamian	et	al.,	(1991)	found	that	10	µM	bumetanide	reduced	CP	water	weight	by	
20	mg	H2O/	g	tissue,	and	Wu	et	al.,	(1998)	observed	a	~9%	reduction	in	the	CSA	of	
dissociated	rodent	CPECs	after	exposure	to	both	10	and	100	µM	bumetanide,	
although	they	only	showed	data	for	the	highest	bumetanide	concentration.		Later	
studies	challenged	these	findings	and	interpretations	based	on	the	observations	that	
bumetanide	at	concentrations	of	100	µM	caused	a	reduction	in	CPEC	volume,	but	
not	at	concentrations	of	10	µM	(Brown,	Davies,	and	Millar,	2009;	Hughes,	
Pakhomova,	&	Brown,	2010).	Both	groups	of	researchers	used	DIC	microscopy	that	
yields	total	cell	volume	and	have	relatively	low-resolution	due	to	edge/	hallow	
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effect,	needing	a	large	number	of	cells	to	increase	the	signal	to	noise	ratio	to	reach	
reliable	conclusions.		We	addressed	this	controversy	by	measuring	changes	in	CWV	
of	CPECs	from	NKCC1+/+	exposed	to	10	µM	bumetanide,	and	ruled	out	unspecific	
effects	of	this	compound	by	using	CPECs	from	NKCC1-/-.	Changes	in	CWV	were	
assessed	by	intracellular	Calcein	dilution,	a	live-cell	imaging	microscopy	method	
that	can	resolve	changes	in	CWV	of	~1%	with	time	resolution	of	0.25	Hz,	and	allows	
osmotic	calibration	of	each	cell	(Crowe,	Altamirano,	Huerto,	&	Alvarez-Leefmans,	
1995;	Alvarez-Leefmans,	1995;	Rocha-Gonzalez	et	al.,	2008).	We	also	used	DIC	live-
cell	imaging	microcopy	to	measure	CSAs	of	isolated	CPECs.	The	rational	is	that	if	
NKCC1	is	constitutively	active	(i.e.,	it	is	always	on),	and	works	in	the	net	ion	and	
water	influx	mode	under	basal	conditions,	then	CPECs	from	NKCC1	KO	mice	should	
also	be	shrunken	compared	with	those	from	WT	mice.	Thus,	shrinkage	occurs	
because	the	net	influx	of	solute	and	water	will	be	reduced	compared	to	the	net	efflux	
of	solute	and	water.	
A	morphometric	comparison	of	the	CSA	of	individual	dissociated	CPECs	
revealed	that	CPECs	from	NKCC1	-/-	mice	were	smaller	than	those	from	WT	mice.		
The	mean	CSA	measurements	from	both	groups	were	normally	distributed.	
Measurements	of	the	cross-sectional	area	of	CPECs	(Figure	4.2)	revealed	that	CPECs	
from	WT	mice	had	a	mean	cross-sectional	area	of	155	±	4.1	μm2	(n	=	44	animals),	
whereas	those	from	NKCC1	KO	mice	had	a	mean	cross-sectional	area	of	137	±	4.8	
μm2,	p	=	0.0106	(n	=	22	animals).	Therefore,	CPECs	from	NKCC1	KO	animals	were	
~18	μm2	smaller	than	those	from	WT.		DIC	images	of	dissociated	CPECs	from	sibling	
WT	and	NKCC1	KO	showed	some	additional	subtle	morphological	differences	
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Figure 4.1: Balance of net solute and water fluxes determines choroidal 
epithelial cell volume. A function of NKCC1 in CPECs is maintenance of both 
normal and constant CWV. Under normal physiological conditions NKCC1 is 
constitutively active, inwardly transporting ions and associated water. Hence, we 
predict that NKCC1 inactivation results in CPEC shrinkage due to unbalanced 
solute and water effluxes. 
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Figure	4.2:	CPECs	from	NKCC1	-/-	mice	are	significantly	smaller	than	
CPECs	from	WT	mice.			Top)	In	vitro	CPECs	from	WT	(left)	and	NKCC1	KO	(right)	
sibling	animals.	CPECs	from	NKCC1	KO	mice	were	visually	smaller	than	those	from	WT	
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mice.	Bottom)	CPECs	from	WT	mice	had	a	mean	cross-sectional	area	of	155	±	4.1	μm2	
(dotted	line	in	box	plot),	n	=	44	animals.	CPECs	from	NKCC1	KO	mice	were	-11.5%	
smaller	than	those	of	the	WT	and	had	a	mean	cross-sectional	area	of	137	±	4.8	μm2,	p	
=	0.0106,	n	=	22	animals.		Boxplot	illustrates	the	spread	of	CSA	measurements	with	
median	CSA	denoted	as	a	black	line,	the	box	represents	the	1st	and	3rd	quartiles,	stems	
represent	quartiles	0	and	4,	and	the	dots	are	those	values	beyond	the	quartile	spread.	
Both	groups	of	measurements	were	fitted	to	a	Gaussian	distribution.		
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between	the	two	groups.		In	the	image	from	NKCC1	+/+,	the	dense	microvilli	of	the	
apical	membrane	were	observed	by	the	bumpy	texture	of	the	CPECs.		In	comparison,	
the	CPECs	from	the	NKCC1	-/-	animal	appeared	slightly	smaller	and	smoother	
suggesting	that	these	cells	were	shrunken.	
Effect	of	Bumetanide	on	cell	water	volume	of	CPECs	from	NKCC1	-/-	and	
NKCC1	+/+	mice	
	
Using	the	pharmacological	approach	to	verify	our	measurements,	we	also	
measured	the	change	in	CWV	of	dissociated	CPECs	loaded	with	Calcein	and	exposed	
to	bumetanide	(Figure	4.3).	When	10	μM	bumetanide	was	applied	to	CPECs	from	
WT	mice	the	cells	shrunk	an	average	of	-15.9	±	9.1%	(n	=	3	animals),	at	an	initial	
rate	of	-5.4	±	0.6	%/	min.		CPECs	from	NKCC1	KO	mice	did	not	respond	to	10	μM	
bumetanide,	mean	volume	change	was	equivalent	to	noise	at	<	±	1%	(-0.5	±	0.7	%,	n	
=	3	animals).		By	treating	CPECs	attached	to	the	cover	slips	as	hemispherical	domes,	
we	used	the	measurements	of	CSA	to	estimate	the	predicted	reduction	in	CWV	of	
NKCC1	-/-	CPECS	and	compared	it	to	that	resulting	from	10	µM	bumetanide	
exposure	(Table	4.1).		What	we	found	was	that	NKCC1	-/-	CPECs	had	a	predicted	
difference	in	CWV	of	approximately	-16%,	which	corresponded	to	the	15.9%	loss	in	
CWV	in	WT	CPECs	that	followed	exposure	to	10	µM	bumetanide.		This	similarity	in	
CWV	loss	suggested	that	10	µM	bumetanide	produced	nearly	complete	inhibition	of	
the	NKCC1	cotransporter	in	CPECs.	In	conclusion,	blocking	NKCC1-mediated	ion	and	
associated	water	fluxes	in	CPECs	by	either	pharmacological	blockade	by	bumetanide	
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or	genetic	ablation	of	NKCC1	resulted	in	CPEC	shrinkage.		These	results	strongly	
suggest	that	on	the	apical	membrane	of	CPECs	NKCC1	is	constitutively	active	and	
functions	in	the	inward	mode.		
External	ion	dependence	of	cell	water	volume	in	CPECs		
	
We	also	examined	the	external	Cl-	and	Na+	dependence	of	CWV	in	CPECs.	By	
examining	the	changes	in	CWV	that	occurred	during	Cl-	uptake	in	the	presence	and	
absence	of	NKCC1,	we	could	infer	the	contribution	of	NKCC1	to	Cl-	loading.	This	
inference	is	possible	given	that	ion	transport	mediated	by	NKCC1	is	tightly	linked	to	
water	transport	in	epithelial	and	non-epithelial	cells	(Hamann	et	al.,	2010;	Rocha-
Gonzalez	et	al.,	2008;	Zeuthen	&	Macaulay,	2012).		The	removal	of	extracellular	Cl-	
(replaced	with	gluconate)	depleted	WT	CPECs	of	Cl-	and	water,	and	resulted	in	a	
mean	cell	shrinkage	of	-20.3	±	1.8%	(n	=	10	animals),	with	an	initial	rate	of	-43.9	±	
8.0	%/min	(Figure	4.4,	A).		This	shrinkage	reversed	when	Cl-	was	reintroduced.	In	
contrast	to	cells	obtained	from	WT	animals,	CPECs	from	NKCC1	KO	mice	only	
shrank	by	-7.7	±	2.1%	(n	=	4	animals),	during	isosmotic	removal	of	Cl-,	with	an	initial	
rate	of	cell	shrinkage	of	-12.7	±	3.9	%/min	(Figure	4.4,	B).		These	results	support	our	
hypothesis	that	NKCC1-mediated	ion	and	associated	water	fluxes	are	constitutively	
active,	inwardly	directed,	and	function	to	maintain	normal	CWV	under	basal	
conditions.	
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Figure	4.3.	Blocking	NKCC1	with	bumetanide	causes	NKCC1	+/+	CPEC	shrinkage.	
Top) volume recording of an individual CPEC from a WT mouse.  The trace 
began with the two ± 10% hypo- / hyperosmotic calibration pulses, prior to the 
application of bumetanide.  In this particular cell, bumetanide caused ~ 13% 
decrease in CWV, which was recovered during the drug wash out.  Bottom) The 
same experiment was repeated in a CPEC from an NKCC1 -/- mouse.  NKCC1 -
/- CPECs responded well to the calibration pulses, but failed to respond to 
bumetanide due to the loss of NKCC1-mediated fluxes. 
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Table	4.1:	Predicted	difference	in	CPEC	volume	using	CPEC	CSA’s	
	
	
Using the mean CSA (from Figure 4.2), the radius was calculated and inserted 
into the formula for the volume of a hemisphere.  The predicted difference in 
volume between the WT and NKCC1 -/- CPECs was very close to mean volume 
difference found by inhibiting the cotransporter with 10 µM bumetanide.  
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Once	CPECs	were	depleted	of	Cl-,	we	observed	the	external	Na+	dependence	
of	CWV	recovery	by	the	simultaneous	replacement	of	extracellular	Cl-	and	removal	
of	extracellular	Na+	(replaced	with	N-methyl-D-glucamine).		By	removing	external	
Na+,	we	inhibited	all	Na+/Cl-	co-transport	into	the	cell.		CWV	recovery	was	partially	
inhibited	in	the	absence	of	Na+,	and	the	volume	recovered	to	-15.8	±	4.0%	(n	=	3	
animals)	during	the	Na+-free	recovery.		About	75	—80%	of	this	CWV	recovery	was	
Na+-dependent.	The	rate	of	volume	recovery	during	the	sodium-independent	
component	(SIC)	was	slower,	2.6	±	0.1%/min,	compared	to	the	rate	during	sodium-
dependent	component	(SDC),	30.2	±	12.6%/min	(n	=	3	animals)	(Figure	4.4,	D).		
Given	that	NKCC1	functions	as	an	active	Cl-	uptake	mechanism	in	other	Cl-	secreting	
epithelia,	it	is	likely	that	the	SDC	of	CWV	recovery	that	followed	CPEC	Cl-	depletion	
was	mediated	by	apical	NKCC1,	and	the	SIC	likely	resulted	from	the	combined	
effects	of	the	Anion	Exchanger	2,	NKATP,	and	osmotically	committed	water	(Brown	
et	al.,	2004).			
	
To	test	the	hypothesis	that	NKCC1	was	contributing	to	the	CWV	recovery	that	
followed	Cl-	depletion,	CWV	recovery	was	examined	in	the	presence	of	bumetanide.	
Volume	recovery	following	CPEC	shrinkage	with	0Cl	in	the	presence	of	bumetanide	
(10	μM)	produced	a	small	bumetanide-independent	volume	recovery	to	-13.0	±	1.2	
%,	with	an	initial	rate	of	8.3	±	0.1	%/min,	followed	by	a	very	slow	bumetanide-
dependent	volume	recovery	when	the	drug	was	washed	off	2.6	±	0.003	%/min	(n	=	
3	animals)	(Figure	4.4,	C).		The	bumetanide-insensitive	(BIC)	and	Na+-independent	
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Figure	4.4:		External	Chloride	and	Sodium	dependence	of	CPEC	CWV.	
Gregoriades, Madaris, Alvarez, and Alvarez-Leefmans (2017, manuscript in 
preparation).  A & B) Isosmotic removal of aCSF Cl- (0Cl) resulted in CPEC 
shrinkage that reversed upon readmission of isosmotic solution (ISO), and 
indicated that external Cl- was required for CWV maintenance. A) Volume 
recording of a CPEC from a WT that shrank -32.4% compared to a CPEC from a 
NKCC1 -/- mouse (B) where the cell shrank -4.8%.  C) CWV recovery was 
reduced in the presence of 10 µM bumetanide. During the bumetanide-
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insensitive component of the volume recovery (BIC), the volume in this cell only 
recovered 1.3%, while most volume was restored during the bumetanide-
sensitive component of the volume recovery (BSC) after the drug was removed. 
D) In the absence of external Na+ there was also incomplete CWV recovery. The 
BIC and Na+-independent (SIC) components indicated the expression of 
mechanisms other than NKCC1 in this volume recovery. BIC mean rate of 
volume recovery was much faster than the BSC mean rate of volume recovery at 
8.3% / min vs 2.6% / min, respectively. The Na+-dependent component (SDC) of 
the recovery proceeded at a rate that was one order of magnitude faster than in 
0Na+ (SIC mean rate of volume recovery was 2.5% / min vs. 30.2% / min during 
SDC). Thus, most of the Cl- fluxes were mediated by Na+-dependent and 
bumetanide-sensitive mechanisms, most likely NKCC1. 
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	(SIC)	components	indicated	the	expression	of	mechanisms	other	than	NKCC1	in	this	
volume	recovery.	However,	most	of	the	water	fluxes	(and	inferred	Cl-	fluxes)	were	
mediated	by	Na+-dependent	and	bumetanide-sensitive	mechanisms,	most	likely	
NKCC1.	
Conclusion	
	
The	data	presented	above	demonstrate	that	basal	NKCC1-mediated	fluxes	
are	inwardly	directed	in	CPECs.		When	NKCC1	was	genetically	ablated	in	the	KO	
mouse	and/or	when	NKCC1	was	inhibited	with	bumetanide,	CPECs	lost	CWV	due	to	
an	imbalance	in	the	net	solute	and	water	fluxes	across	the	cell.		Additionally,	full	
recovery	from	a	loss	of	cell	water	and	intracellular	Cl-	required	the	presence	of	
external	Na+	and	was	bumetanide	sensitive.	This	supports	the	hypothesis	that	
NKCC1	is	constitutively	active	and	functions	in	the	maintenance	of	both	normal	and	
constant	CWV	in	CPECs.	 	
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Chapter	5:	Specific	Aim	2	Results	
	
The	experiments	in	this	chapter	focus	on	answering	the	following	questions:	
1) What	are	the	[Na+]i	and	[Cl-]i	of	mammalian	CPECs?	
2) Do	the	[Na+]i	and	[Cl-]i	change	in	CPECs	from	NKCC1	-/-?	
3) Can	apical	NKCC1	act	as	a	sensor	and	regulator	of	CSF	[K+]	in	CPECs?	
The	link	between	these	questions	became	evident	while	attempting	to	create	a	
predictive	model	of	NKCC1	cotransport	in	relation	to	CSF	[K+].	At	that	time,	we	came	
across	very	different	values	for	the	intracellular	ion	concentrations	of	CPECs,	and	
quickly	realized	the	necessity	to	measure	these	concentrations	ourselves	(see	next	
section).		Without	these	data,	it	would	have	been	impossible	to	make	our	model	
realistic.	Answering	the	first	question	involved	using	the	ion-sensitive	dyes	ANG-2	
and	MQAE	to	determine	the	intracellular	Na+	and	Cl-	concentrations,	respectively.	To	
answer	the	second	question,	we	examined	the	sensitivity	of	CPECs	to	small	changes	
in	external	[K+]	within	a	physiological	plausible	range.		
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Figure	5.1:	Measuring	[Na+]i	in	single	CPECs	using	ANG-	2.	Top) Measurement of 
basal [Na+]i in a NKCC1 +/+ CPEC loaded with ANG-2. The basal [Na+]i of this 
CPEC was 9 mM. After taking the basal [Na+]i measurement, NKATP was 
inhibited with ouabain (1 mM) to test that the dye responded to changes in [Na+]i. 
In this CPEC, ouabain exposure resulted in an increase in [Na+]i to ~45 mM, 
which was reversible upon the removal of ouabain. Bottom Left) Fitting the 
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Michaelis-Menton equation to the plot of the relative fluorescence (1-Fo/Ft) of 
ANG-2 vs [Na+] provided Kd and Fmax values for each cell. These values were 
used to convert fluorescence intensities into [Na+].  Bottom Right) Histogram 
showing the distribution of [Na+]i  in the 21 individual CPECs.  The mean [Na+]i of 
CPECs was 8.4 ± 1.0 mM, n = 3 animals.	
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Intracellular	Na+	and	Cl-	concentrations	of	mouse	CPECs		
	
	Using	ANG-2,	we	found	that	[Na+]i	of	WT	CPECs	was	8.4	±	1.0	mM	(n	=	3	
animals),	as	shown	in	Figure	5.1.		This	Na+	concentration	was	closer	to	the	values	of	
10	–15	mM	measured	in	amphibians	(Saito	&	Wright,	1987;	Zeuthen,	1994)	using	
ion-selective	microelectrodes,	but	differed	greatly	to	the	[Na+]i	measured	by	
Johanson	and	Murphey	(1990)	and	Smith	and	Johanson	(1985)	using	whole	tissue/	
flame	photometry,	or	that	by	Keep	et	al.,	(1994)	in	their	calculations	to	determine	
the	direction	of	cotransport.	The	average	values	of	[Na+]i	obtained	or	assumed	by	
Johanson,	Keep,	and	coworkers	ranged	between	30	-48	mM.	Our	measured	[Na+]i	
was	consistent	with	[Na+]i	measured	in	a	number	of	epithelial	and	non-epithelial	
cells	using	fluorescent	dyes	or	microelectrodes	(Donoso,	Mill,	O'Neill,	&	Eisner,	
1992;	Rose	&	Ransom,	1996;	Zeuthen,	1978,	1994;	Zhao	&	Muallem,	1995).	In	
Figure	5.2,	a	comparison	of	the	ion	concentrations	presented	by	Johanson	and	
Murphey	(1990),	Keep	et	al.,	(1994),	Saito	and	Wright	(1987),	and	our	measured	
intracellular	Na+	and	Cl-	concentrations	was	made.	We	were	unable	to	measure	the	
[K+]i	in	CPECs	because	so	far	there	are	no	reliable	dyes	for	this	cation,	so	we	used	an	
[K+]i	=	110	mM	based	on	the	range	of	values	obtained	by	Zeuthen	et	al.,	(1987)	using	
ion-selective	microelectrodes	in	amphibian	CP	of	100-120mM	(Zeuthen,	
Christensen,	Baerentsen,	&	la	Cour,	1987).		
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Figure	5.2:		Effect	of	[Na+]i	on	the	net	free	energy	driving	NKCC1	transport	in	
CPECs. Measurements using the fluorescent indicator dye ANG-2 revealed that 
mouse CPECs had an [Na+]i = 8.4 ± 1.0 mM, similar to that of amphibian CPECs, 
10.5 mM, measured by Dr. Zeuthen using ion-selective microelectrodes and 
reported by Saito & Wright (1987). Using the measured values for [Na+]i and [Cl-]i 
in equation 1, we found DµNKCC1 was negative, indicating that under basal 
conditions the cotransporter is working in the inward direction. 
Modeling the direction of NKCC1 mediated net fluxes in CPECs using 
measured and reported intracellular ion concentrations
∆μ NKCC1 was calculated using the equation below and reported extracellular and intracellular ion concentrations. Based on 
CWV measurements and CSF ion concentrations, we predict [Na+]i must be significantly lower than reported in mamma-
lian CPECs and closer to that measured using ion-selective microelectrodes in amphibian CPECs (Saito & Wright, 1987).
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Table	5.1:	CPEC	intracellular	ion	concentrations	used	to	calculate	DµNKCC1.	
	
[Na+]i 
(mM) 
[Cl-]i 
(mM) 
[K+]i 
(mM) 
[Na+]o 
(mM) 
[Cl-]o 
(mM) 
[K+]o 
(mM) 
Johanson & Murphy (1990) 48 65 145 154 128 3 
Keep et al., (1994) 30 50 120 150 130 3 
Saito & Wright (1987) 10.5 31.6 90 110 89 2 
Our Measured Values 8.4 62.1 110* 126 131 3 
	
The	top	two	rows	represent	values	for	mammalian	CPECs,	while	Saito	&	Wright	
used	amphibian	CPECs.		The	values	for	[Na+]i	reported	for	mammalian	CPEC	are	
very	large	compared	to	the	value	for	amphibian	CPEC.	*estimate	value	based	on	
the	range	of	values	obtained	by	using	ion-selective	microelectrodes	in	amphibian	
CP	of	100	-120	mM	(Zeuthen	et	al.,	1987).	The	same	value	has	been	obtained	in	
glioma	cells	using	the	fluorescent	indicator	PBFI-AM	(Zhu	et	al.,	2014).	
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	Using	MQAE	we	found	[Cl-]i	of	NKCC1	WT	CPECs	was	62.1	±	3.5	mM	(n	=	5	
animals),	a	concentration	that	was	close	to	that	reported	for	other	mammalian	CPEC	
(Johanson	&	Murphy,	1990).		Both	mammalian	[Cl-]i	measurements	were	about	1.5X	
greater	than	those	of	amphibian	CPECs	using	ion-selective	microelectrodes,	which	
were	approximately	40	mM	(Saito	&	Wright,	1987;	Zeuthen,	1987).			
We	used	the	same	methodological	approach	to	measure	[Na+]i	and	[Cl-]i	in	
CPECs	from	NKCC1	-/-	mice.	The	results	show	that	[Na+]i	was	12.2	±	1.2	mM	(n	=	3	
animals),	a	value	that	was	not	significantly	different	to	that	in	WT	CPECs	(p	=	0.07).	
In	contrast,	the	[Cl-]i	of	NKCC1	-/-	CPECs	was	significantly	less	than	that	of	WT	cells;	
[Cl-]i	of	NKCC1	-/-	CPECs	was	31.5	±	4.8	(n	=	7	animals),	which	was	significantly	
different	(p	<0.001)	to	that	of	WT	(Figure	5.3).		This	decrease	in	intracellular	[Cl-]	by	
about	-50%	is	consistent	with	NKCC1	being	a	major	Cl-	uptake	system	that	
maintains	[Cl-]i	and	cell	volume	at	a	level	needed	for	the	cells	to	work.	Knowing	both	
the	intra-	and	extracellular	[Cl-],	it	was	possible	to	estimate	the	chloride	equilibrium	
potential	(ECl)	in	WT	and	KO	CPECs	using	equation	5.	The	ECl	was	then	be	compared	
to	the	membrane	potential	(Em)	of	-53	mV,	a	value	recorded	in	rat	CPECs	(Kotera	&	
Brown,	1994),	to	determine	whether	Cl-	was	passively	distributed	across	the	
membrane	or	actively	maintained	above	chemical	equilibrium	in	CPECs.		The	
estimated	mean	ECl	of	NKCC1	+/+	CPECs	was	-19.71	±	1.4	mV	(assuming	all	the	cells	
had	the	same	Em,	which	obviously	renders	this	calculation	as	a	valid,	but	rough	
estimate).		All	of	the	WT	CPEC	had	estimated	ECl	values	that	were	less	negative	than	
expected	if	Cl-	was	maintained	above	electrochemical	equilibrium	in	CPECs.	The	
estimated	mean	ECl	in	NKCC1	-/-	CPECs	was	-38.9	±	4.2	mV	(n=	7	animals),	a	value
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Figure	5.3:	Measuring	[Cl-]I	in	single	CPECs.	Representative examples of NKCC1 
+/+ and NKCC1 -/- Cl- transients that measured the [Cl-]i and ECl of single CPECs 
loaded with MQAE.  CPECs became depleted of their internal Cl- stores when 
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the external Cl- was removed (0Cl-), and were able to recover to initial values 
when external Cl- was replaced. The difference between the ISO and 0Cl- 
steady-states (gray arrow) was used to calculate the [Cl-]i. The inset is the 
calibration plot of the relative MQAE fluorescence (Fo/Ft) as a function of [Cl-] in 
the calibration solutions, and the slope of this relationship is the Stern-Volmer 
constant (KSV). Top) Cl- transient from NKCC1 +/+ CPEC.  The [Cl-]i measured in 
this cell was 62.9 mM, the KSV = 19.7 M-1, and ECl was calculated at -18.9 mV.  
Bottom) Cl- transient from NKCC1 -/- CPEC. The [Cl-]i in this was measured to 
be 22.9 mM, KSV = 8 M-1, and ECl was calculated at -44.8 mV.    NKCC1 -/- 
CPECs had a reduction in [Cl-]i by 50% compared to WT. NKCC1 -/- CPECs also 
had a reduced KSV, which may have been a consequence of the reduced CWV, 
however further investigation on this matter is necessary.  
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that	was	more	negative	than	that	of	the	WT,	but	still	more	positive	than	Em	by	about	
10	mV.		These	estimates	must	be	taken	with	caution	because	the	actual	Em	was	not	
measured	in	the	present	study.	However,	it	is	worth	mentioning	that	of	the	7	NKCC1	
-/-	animals	in	this	study,	2	had	an	estimated	mean	ECl	more	negative	than	-50	mV.	
Meaning	that	in	some	animals,	Cl-	was	passively	distributed	across	the	CPEC	plasma	
membrane.		
	
Testing	the	sensitivity	of	NKCC1	in	CPECs	to	small	changes	in	[K+]o.		
	
The	net	free	energy	driving	NKCC1	depends	on	the	extracellular	and	
intracellular	concentrations	of	the	cotransported	ions	(Na+,	K+,	and	Cl-),	and	the	
stoichiometry	(see	equation	1).		Equation	1	predicts	that	relatively	modest	changes	
in	[K+]o	have	a	big	impact	on	ΔμNKCC1	(Figure	5.4).	Figure	5.4	illustrates	how	the	
[K+]CSF	of	2.9	–3	mM	resulted	in	the	cotransporter	working	nearer	to	its	flux	reversal	
point	(FRP),	where	the	chemical	potential	driving	force	of	NKCC1	(ΔμNKCC1)	is	equal	
to	zero,	as	compared	to	the	more	negative	value	of		ΔμNKCC1	when	[K+]o	is	4.7	–5	mM,	
as	in	the	plasma.	Specifically,	the	FRP	of	NKCC1	in	CPECs	occurred	between	1.4	–	1.6	
mM	[K+]o	when	using	the	measured	[Na+]i		and	[Cl-]i	,	and	the	estimate	of	[K+]i	of	110	
mM	reported	by	Zeuthen	et	al.,	(1987).		When	[K+]o	dropped	below	the	FRP,	the	
model	predicted	that	NKCC1	would	reverse	direction	and	ion	cotransport	would	
occur	in	the	outward	mode.		We	can	think	of	this	thermodynamic	model	in	vector	
terms,	with	each	point	on	the	graph	representing	both	a	direction	of	cotransport	
and	magnitude	of	the	driving	force.		The	farther	away	a	point	is	from	zero,	the	
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greater	the	driving	force	of	NKCC1	cotransport.		Additionally,	the	curve	of	ΔμNKCC1	vs	
[K+]o	became	increasingly	steep	as	[K+]o	decreased.		This	is	due	to	the	stoichiometry	
of	NKCC1.		Cotransport	mediated	by	NKCC1	requires	the	binding	of	2	Cl-,	which	
results	in	the	internal	and	external	[Cl-]	to	be	raised	to	the	power	of	2	in	equation	1.		
As	[K+]o	decreases	to	1	mM,	the	influence	of	[Cl-]o	on	NKCC1	transport	increases.	
When	[K+]o	becomes	less	than	1	mM,	the	product	of	the	denominator	in	equation	1	
approaches	zero.	A	small	change	in	the	[K+]o	of	±	2	mM	K+	with	respect	to	the	basal	
level	of	3	mM,	is	sufficient	to	reverse	the	sign	of		ΔμNKCC1	indicating	a	change	in	the	
direction	of	cotransport.		In	the	experiments	that	follow,	we	tested	the	sensitivity	of	
dissociated	CPECs	in	vitro	to	±	2	mM	changes	in	[K+]o.	We	used	measured	changes	in	
the	CWV	of	CPECs	that	occurred	in	response	to	changes	in	[K+]o,	as	an	indicator	of	
the	net	flux	direction	and	magnitude,	and	utilized	the	two-prong	approach	to	NKCC1	
transport	inactivation	as	in	Chapter	4.			
One	of	the	central	hypotheses	of	this	work	is	that	apical	NKCC1	of	CPECs	is	
highly	sensitive	to	changes	in	[K+]CSF.	This	is	predictable	given	that	the	cotransporter	
is	in	the	apical	membrane,	which	is	in	direct	contact	with	the	CSF,	and	because	of	the	
net	free	energy	driving	the	cotransporter,	as	discussed	above	(equation	1),	and	the	
Km	for	K+	of	NKCC1	(Payne	&	Forbush,	1995).	An	isosmotic	decrease	in	[K+]o	by	2	
mM	(i.e.,	from	baseline	3	mM	to	1	mM)	produced	a	mean	CPEC	shrinkage	of	-11.8	±	
1.7%	(n	=	11	animals),	that	proceeded	at	an	initial	rate	of	-12.0	±	1.4%	/	min.		An	
isosmotic	increase	in	[K+]o	by	2	mM	(i.e.,	from	3	mM	to	5	mM),	caused	CPECs	to	
swell	by	10.4	±	1.6%	(n	=	8	animals),	and	the	initial	rate	of	that	swelling	was	8.3	±	
1.0%	/	min.	CPECs	from	NKCC1	KO	mice	had	no	change	in	CWV	in	response	to	
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Figure 5.4: Modeling the FRP of NKCC1 as a function of [K+]o in CSF and artificial CSF (aCSF).		Plot of Dµ of 
NKCC1 as a function of [K+]o in CSF (red) or in aCSF (black).  The NKCC1 mediated fluxes reverse when Dµ=0 (FRP), 
which occurs in this model when [K+]o is 1.4 mM (CSF) or 1.6 mM (aCSF).  This indicates that under physiological [K+]o 
(2.9-3 mM) NKCC1 works in the inward mode, near thermodynamic equilibrium. Dµ is calculated at T= 295 K for aCSF 
and T= 310 K for CSF. The FRP is unchanged for temperatures between 295 -310 K.
Both direction and magnitude of the overall net free en-
ergy driving NKCC1 transport (Δμ) can be predicted using 
the ion concentrations shown in the table below. For an 
electroneutral stoichiometry of 1Na+:1K+:2Cl-,
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±	2	mM	changes	in	[K+]o,	which	indicated	that	they	lost	this	“K+-sensitivity.”	
Specifically,	after	5	minutes	of	exposure	to	1	mM	K+	and	5	mM	K+,	the	mean	CWV	
change	in	NKCC1	-/-cells	was	within	the	noise	level	of	<	1%	(n	=	3	animals	for	each).	
Figure	5.5	provides	a	comparison	between	the	traces	obtained	from	single	WT	
CPECs	vs	NKCC1	-/-	CPECs.		There	was	a	striking	difference	in	the	volume	response	
to	changes	in	[K+]o	between	the	two	representative	cells.		In	the	top	trace,	the	WT	
CPEC	showed	a	robust	shrinkage	in	response	to	lowering	the	[K+]o	just	2	mM,	that	
reversed	upon	exposure	to	baseline	3	mM	K+.	The	cells	swelled	in	response	to	
increasing	[K+]o	from	3	mM	to	5	mM.		These	responses	were	absent	in	NKCC1	-/-	
CPECs,	as	shown	in	the	lower	panel	of	Fig.	5.5.		To	further	prove	that	the	previous	
results	were	due	to	specific	inactivation	of	NKCC1-mediated	fluxes	and	not	to	some	
unknown	change	related	to	the	genetic	mutant,	such	as	a	change	in	the	location	or	a	
functional	alteration	of	other	membrane	proteins	(e.g.,	NKATP	or	aquaporin	1	
(AQP1)),	the	changes	in	CPE	CWV	in	response	to	±	2	mM	K+	were	repeated	in	cells	
from	NKCC1	+/+	in	the	presence	of	10	μM	bumetanide,	a	concentration	expected	to	
block	NKCC1	(Alvarez-Leefmans,	2012;	Russell,	2000).		As	illustrated	in	Figure	5.6,	
CPECs	responded	to	two	sequential	changes	in	external	[K+].	Pharmacologic	
inhibition	of	NKCC1	with	10	μM	bumetanide	resulted	in	CPEC	shrinkage,	as	
expected	from	halting	constitutively	active	NKCC1,	that	blocked	the	“sensitivity”	to	
the	changes	in	[K+]o	which	was	clearly	mediated	by	NKCC1.	Bumetanide	produced	
CPEC	shrinkage	and	blocked	the	cell’s	ability	to	swell	in	response	to	a	second	
exposure	of	5	mM	K+	(Figure	5.6C).			Similarly,	in	the	presence	of	bumetanide	CPEC	
shrinkage	when	[K+]o	was	decreased	to	1	mM	K+	did	not	occur	(Fig.	5.6D).		However,
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Figure 5.5: Comparison of the changes in relative cell volume of CPECs in 
response to various [K+]o in cells dissociated from NKCC1 +/+ and NKCC1 -
/- animals.	Top trace illustrates the CPEC volume sensitivity to ±  2 mM changes 
in [K+]o, and the bottom trace the experiment was repeated in an NKCC1 -/- 
CPEC.  Top) WT CPEC shrank by -20.6% when K+ was lowered to 1 mM, and 
swelled 10.0% above its basal volume when K+ was increased to 5 mM. Bottom) 
NKCC1 -/- CPEC does not respond to±  2 mM changes in [K+]o. Both cells were 
able to respond to the ± 10% anisosmotic calibrations. Thus, in the absence of 
NKCC1, CPECs lose the ability to respond to ± 2 mM changes in external [K+].
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Figure 5.6.  CPEC sensitivity to changes in [K+]o was blocked by 
bumetanide. A & B) Isosmotic changes in cell water volume induced in CPECs 
by altering [K+]o ± 2 mM K+ were blocked by bumetanide. (A) CWV changes in 
response to two sequential 5K pulses (from 3 to 5 mM K+) (B) Similar to A, but 
the sequential pulses were 1K (from 3 to 1 mM K+). There was a slight decrease 
in the amplitude of the second K+ pulse compared to the first, but the effect of the 
second K+ pulse was reproducible and of sufficient amplitude to be used as test 
pulse in the experiments shown in the second part of this figure to probe the 
effect of bumetanide.  In trace A, the first 5 mM K+ pulse produced a swelling of 
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8.0% compared to a swelling of 6.8% in the second pulse.  Differences between 
the first and second 1 mM K+ pulses (B) were larger. The shrinkage during the 
first 1 mM K+ pulse was -12.4% verses -7.9% during the second 1 mM K+ pulse. 
C & D) Inhibition of NKCC1 with 10 μM bumetanide resulted in CPEC shrinkage 
and loss of the response to small changes in [K+]o.  Following a control pulse of 5 
mM K+ (C) or 1 mM K+ (D), the application of bumetanide produced CPEC 
shrinkage and blocked the cell’s ability to response to a second ± 2 mM change 
in [K+]o.   
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Figure 5.7: Cell water volume recovery following 1 mM K+ isosmotic 
shrinkage was bumetanide-sensitive in CPECs from NKCC1 +/+. CWV 
recovery from shrinkage produced by exposure to 1K was blunted in the 
presence of 10 µM bumetanide. However, there was a small bumetanide-
insensitive component (BIC) of the recovery. During the BIC, the volume in this 
cell recovered from -7.2 to -5.1 %, and the remaining volume recovery occurred 
during the relative bumetanide-sensitive component (rBSC) after the drug was 
removed. The BIC indicates the possibility of mechanisms other than NKCC1 in 
this volume recovery. BIC mean rate of volume recovery is 0.71 % / min 
compared to the rBSC mean rate of volume recovery at 1.3 % / min.	
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CPECs	presented	a	modest	volume	recovery	from	shrinkage	in	the	presence	of	
bumetanide	to	a	mean	volume	of	-5.2	±	0.1%	(n	=	3	animals)	(Figure	5.7).	The	
bumetanide-insensitive	(BIC)	component	of	the	CWV	suggested	either	incomplete	
block	of	NKCC1,	or	the	expression	of	mechanisms	other	than	NKCC1	in	this	volume	
recovery.	BIC	mean	rate	of	volume	recovery	was	the	same	as	the	relative	
bumetanide-sensitive	component	(rBSC)	mean	rate	of	volume	recovery	at	
1.2%/min,	indicating	that	possibly	the	same	mechanism	was	responsible	for	both	
components	of	the	recovery.	These	results	are	consistent	with	our	data	using	NKCC1	
KO	mice,	and	reveal	that	the	[K+]o	sensitivity	of	CPECs	was	dependent	on	NKCC1-
mediated	fluxes.	
Testing	the	sensitivity	of	NKCC1	to	various	[K+]o	with	solutions	buffered	with	
CO2/HCO-3	
	
The	previous	experiments	were	performed	using	HEPES	buffered	solutions	
equilibrated	in	air.	Under	these	conditions,	atmospheric	CO2	is	able	to	dissolve	into	
the	solutions,	leading	to	CO2	hydration	and	consequent	formation	of	H2CO3,	which	
dissociates	to	form	H+	and	HCO3-	(Praetorius	&	Damkier,	2017).	Further,	cell	
metabolism	results	in	the	production	of	intracellular	CO2	which	reacts	with	
intracellular	water	also	forming	HCO3-.	Given	the	presence	of	extracellular	and	
intracellular	membrane	bound	carbonic	anhydrases	(CA)	in	CPECs	(reviewed	in	
Praetorius	&	Damkier,	2017),	the	CO2	hydration	reactions	are	catalyzed	both	in	the	
intra-	and	extra-cellular	membrane	domains.	Thus,	HEPES	solutions	equilibrated	
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with	air	do	have	sufficient	bicarbonate	to	drive	bicarbonate-dependent	
transporters.		This	effect	is	enhanced	because	the	major	bicarbonate	transporters	
physically	or	functionally	interact	with	the	various	intra-	or	extra-cellular	CAs	
isoforms,	forming	supramolecular	complexes	known	as	“metabolons”	(Deitmer	&	
Becker,	2013;	Deitmer,	Theparambil,	Ruminot,	&	Becker,	2014;	McMurtrie	et	al.,	
2004).	CPECs	have	a	high	concentration	of	CA’s	that	catalyze	the	hydration	of	CO2	
thereby	forming	H+	and	HCO3-	(Fisher	&	Copenhaver,	1959;	Giacobini,	1961,	1962;	
Maren,	1967;	Masuzawa,	Shimabukuro,	Sato,	&	Saito,	1981).		A	reason	for	
performing	experiments	using	HEPES-buffered	solutions	equilibrated	with	air	is	
that	it	is	easier	to	maintain	a	constant	pH	compared	to	CO2/HCO3-,	when	running	the	
solutions	through	perfusion	lines.	Further,	experiments	using	HCO3-	buffered	aCSF	
showed	that	WT	CPECs	responded	similarly	to	changes	in	[K+]o	in	either	HEPES	or	
HCO3-	buffered	solutions	(Figure	5.8).	In	HCO3-	buffered	solutions	the	mean	
shrinkage	in	response	to	1	mM	K+	was	-13.1	±	2.3	%	(n	=	4	animals)	and	the	mean	
swelling	in	response	to	5	mM	K+	was	16.6	±	2.9	%	(n	=	4	animals),	with	p	=	0.69	and	
0.07,	respectively,	when	compared	to	their	corresponding	responses	in	HEPES	
buffered	solutions.	Table	5.2	summarizes	the	data	below.	It	is	important	to	mention	
that	K+	induced	responses	showed	considerable	variability	between	cells,	possibly	
due	to	variations	in	the	content	of	intracellular	ions	affecting	NKCC1	transport.	
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Figure 5.8: CPEC K+ sensitivity was unchanged in the presence of added 
HCO3- to the bathing solutions. Two representative cells showing the CWV 
response to ± 2 mM K+ in CO2/ HCO3- buffered bathing solutions. No significant 
differences were found between the K+ sensitivity of CPECs in bicarbonate 
buffered solutions vs HEPES buffered solutions. Top) A WT CPEC was exposed 
to 1 mM K+ and this particular cell shrank -18.1 %.  Bottom) This WT CPEC was 
exposed to 5 mM K+ and swelled 19.1 %.
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Table	5.2:		Comparing	the	changes	in	CWV	in	response	to	±	2	mM	K+	when	the	
bathing	solutions	are	buffered	with	HEPES	vs	CO2/HCO3-.	
	
Buffer 1 mM K+ 
DVolume 
5 mM K+ 
DVolume 
HEPES -11.8 ± 1.7% 10.4 ± 1.6%  
 n = 11 animals n = 8 animals 
CO2/HCO3- -13.1 ± 2.3 % 16.6 ± 2.9 % 
 n = 4 animals n = 4 animals 
Significance P = 0.69 P =0.07 
	
A comparison of the K+-induced changes in CWV in differently buffered bathing 
solutions.  
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Conclusion	
CPECs	had	an	[Na+]i		=	8.4	mM	and	an	[Cl-]i	=	62.1	mM.		These	concentrations	
support	the	hypothesis	that	in	CPECs	NKCC1	functions	near	to	its	FRP.		CPECs	were	
exquisitely	sensitive	to	small	changes	in	[K+]o	in	the	physiological	range	of	±	2	mM.	
In	the	absence	of	NKCC1-mediated	fluxes,	either	by	pharmacological	inhibition	or	
genetic	ablation	using	the	NKCC1	-/-	mouse,	CPECs	lost	this	[K+]o	sensitivity.		This	
loss	in	sensitivity	was	not	the	result	of	altered	NKATP	or	AQP1	expression	on	the	
apical	membrane	of	NKCC1	-/-	CPECs	(see	Appendix	A).		Thus,	we	propose	that	the	
CPECs	use	NKCC1	as	a	sensor	and	regulator	of	CSF	[K+].
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Chapter	6:	Discussion	
	
The	results	in	this	dissertation	contribute	to	elucidating	the	function	of	the	
apical	NKCC1	cotransporter	in	CPECs,	with	a	focus	on	determining	1)	the	direction	
of	NKCC1	cotransport	under	basal	conditions;	and	2)	whether	NKCC1	works	near	to	
its	FRP,	thus	permitting	it	to	function	as	a	sensor	and	regulator	of	CSF	[K+].		These	
data	include	a	three-pronged	approach	to	NKCC1	inactivation,	utilizing	NKCC1	-/-	
mouse,	pharmacological	inhibition	of	NKCC1	with	bumetanide,	and	ion-substitution	
experiments.		
NKCC1	inactivation	by	either	genetic	ablation	or	pharmacological	inhibition	
reduces	CPEC	water	volume	by	~16%	(Figure	4.2,	4.3,	and	Table	4.1).	Ion-
substitution	experiments	demonstrate	that	maintenance	of	normal	CPEC	water	
volume	requires	the	presence	of	external	Cl-	and	Na+,	and	is	bumetanide-sensitive	
(Fig.	4.4).	These	data	prove	that	NKCC1	is	constitutively	active	and	inwardly	
directed	in	CPECs	under	basal	physiological	conditions,	solving	a	long-standing	
controversy	in	the	field.	Further,	the	results	of	the	present	study	establish	that	a	
critical	function	of	NKCC1	in	CPECs	is	the	maintenance	of	both	normal	and	constant	
CWV,	that	we	propose	is	needed	for	CSF	secretion.	
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Reported	[Na+]i	of	CPECs	range	from	10	–15	mM	in	amphibians,	and	30	–50	mM	
in	mammals	(Figure	5.2	and	Table	5.1)	(Johanson	&	Murphy,	1990;	Keep	et	al.,	1994;	
Saito	&	Wright,	1987;	Zeuthen	et	al.,	1987).		Using	the	non-invasive	Na+-indicator,	
ANG-2,	the	[Na+]i	measurement	of	mouse	CPECs	is	8.4	±	1.0	mM	(Figure	5.1),	a	value	
much	less	than	is	reported	for	mammalian	CPECs	(30	-50	mM)	from	whole	tissue,	
but	closer	to	the	10	–15	mM	measured	in	single	CPECs	of	amphibian	using	ion-
selective	microelectrodes.	The	ANG-2	[Na+]i	measurements	require	the	calibration	
of	every	cell	in	order	to	determine	the	individual	Kd	of	each	cell.	The	verifies	that	
the	calibration	solutions	of	permeabilized	cells	do	not	give	spurious	values	due	to	
changes	in	cell	volume,	a	very	important	control	for	a	single	excitation/emission	
dye.	
NKCC1	-/-	CPECs	have	~50%	reduction	in	[Cl-]i	(31.5	±	4.8,	n	=	7	animals,	p	
<0.001)	compared	to	WT	(62.1	±	3.5	mM,	n	=	5	animals),	and	in	both	WT	and	KO	
CPECs,	intracellular	Cl-	is	maintained	above	chemical	equilibrium	(Figure	5.3).	
Estimates	of	ECl	were	made	using	measured	[Cl-]i	but	assuming	a	constant	Em,	and	
are	consequently	considered	preliminary.	Nevertheless,	the	results	suggest	that	in	
the	absence	of	NKCC1,	these	cells	are	endowed	with	other	Cl-	uptake	mechanisms,	a	
situation	similar	to	that	reported	for	NKCC1-/-	olfactory	neurons	and	DRG	neurons	
(Alvarez-Leefmans	&	Mao,	2015;	Nickell,	Kleene,	&	Kleene,	2007).	
	 Using	these	measurements	for	intracellular	[Na+]	and	[Cl-],	a	model	of	the	net	
free	energy	driving	NKCC1	cotransport	can	be	created	(Figure	5.4).		This	model	is	
consistent	with	the	hypothesis	that	NKCC1	is	working	in	the	inward	direction	and	
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relatively	near	to	thermodynamic	equilibrium,	or	its	FRP,	when	[K+]o	is	3	mM,	which	
is	the	physiological	concentration	in	CSF.	Since	NKCC1-mediated	fluxes	are	tightly	
linked	to	water	fluxes	(Figure	2.2),	changes	in	CWV	act	as	a	surrogate	for	measuring	
NKCC1-mediated	K+	fluxes	in	CPECs	(Alvarez-Leefmans,	2012;	Hamann	et	al.,	2005;	
Hamann	et	al.,	2010;	Rocha-Gonzalez	et	al.,	2008;	Zeuthen	&	Macaulay,	2012).		
Results	show	that	CPECs	are	exquisitely	sensitive	to	changes	in	[K+]o;	varying	[K+]o	
as	little	as	±	2	mM,	keeping	the	osmolality	constant	i.e.,	isosmotic	with	respect	to	the	
control	solution,	is	sufficient	to	produce	changes	in	CWV	of	±	10	%	or	greater	
(Figure	5.5),	indicating	that	NKCC1	reverses	transport	direction.		Although	this	
reversibility	is	predicted	on	thermodynamic	grounds	(Alvarez-Leefmans,	2012;	
Russell,	2000),	to	our	knowledge,	this	is	the	first	demonstration	of	this	property	of	
NKCC1.	That	the	changes	in	CWV	are	specifically	mediated	by	NKCC1,	is	evident	
given	that	NKCC1	-/-	CPECs	do	not	respond	these	changes	in	[K+]o,	thus	these	cells	
lose	their	external	“K+	sensitivity”.	As	expected	from	the	NKCC1	-/-	experiments,	
pharmacologic	inhibition	of	NKCC1	with	10	µM	bumetanide	blocks	the	response	to	
changing	[K+]o	in	WT	CPECs.	These	results	not	only	prove	the	reversibility	of	NKCC1	
transport,	but	strongly	suggest	that	NKCC1	can	function	as	a	sensor	and	regulator	of	
[K+]o	in	CPECs.	
The	direction	of	NKCC1	cotransport	in	CPECs	
	
To	understand	the	functional	role	of	apical	NKCC1	in	CPECs,	it	is	critical	to	
determine	the	direction	of	NKCC1	transport	under	basal	physiological	conditions.	
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Outwardly	directed	NKCC1	transport,	operating	in	the	net	efflux	mode,	would	
function	solely	as	a	CSF	secretion	mechanism.	Conversely,	an	inwardly	directed	
NKCC1	transport	would	have	an	absorptive	function	and	contribute	to	maintenance	
of	CWV.	The	direction	of	NKCC1	cotransport	has	been	debated	since	it	was	first	
hypothesized	that	the	cotransporter	is	located	to	the	apical	membrane	of	CPECs	by	
Keep	et	al.,	(1994),	which	was	later	demonstrated	by	Plotkin	et	al.,	(1997)	using	
immunofluorescence	microscopy	with	NKCC1	specific	antibodies	(Plotkin	et	al.,	
1997).	The	apical	location	generates	a	debate	because	NKCC1	expression	usually	
occurs	in	the	basolateral	membrane	of	secretory	epithelia.	In	1998,	Wu	et	al.	
provided	evidence	in	individual	CPECs	that	contradicts	the	claims	made	by	Keep	et	
al.,	(1994),	and	supports	NKCC1	functioning	in	the	inward	direction	(Wu	et	al.,	
1998).		The	present	findings	confirm	and	extend	those	of	Wu	and	colleagues.		
CPECs	maintain	normal	cell	volume	through	a	balance	of	net	solute	and	
water	influx	to	efflux.		As	illustrated	in	Figure	6.1,	basolateral	Na+	and	HCO3-	influx	
occurs	through	the	Na+/	HCO3-	Cl-	exchanger	(NBCE)	and	the	electroneutral	
Na+/HCO3-	cotransporter	(NBCn1),	and	Cl-	uptake	occurs	via	the	anion	exchanger	2	
(AE2)	(Praetorius	&	Damkier,	2017).	There	is	basolateral	efflux	of	HCO3-	via	AE2	and	
Cl-	via	NCBE,	with	the	additional	K-Cl	efflux	through	KCC3a	(Praetorius	&	Damkier,	
2017).	On	the	apical	membrane,	K+	influx	occurs	mostly	through	NKATP	and	NKCC1.		
Apical	Na+	influx	by	the	Na+/	H+	exchanger	(NHE1),	and	Na+	and	Cl-	influx	through	
NKCC1	(Praetorius	&	Damkier,	2017).		Both	outward	and	inward	rectifying	K+	
channels	(Kv	1.1,	Kv	1.3,	Kir	7.1,	KCNQ1,	and	KCNE2)	are	present	on	the	apical	
membrane	to	facilitate	K+	recycling	to	the	lumen,	in	addition	to	volume	activated	K-
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Cl-	efflux	through	KCC4	(Praetorius	&	Damkier,	2017).	While	most	of	the	Cl-	efflux	is	
carried	by	the	volume	activated	and	inward	rectifying	Cl-	channels	(Clir	and	VRAC)	
(Praetorius	&	Damkier,	2017).		Apical	Na+	efflux	by	NKATP	and	the	electrogenic	
Na+/	HCO3-	cotransporter	(NBCe2),	along	with	HCO3-	efflux	via	NBCe2	and	H+	efflux	
via	NHE1	(Praetorius	&	Damkier,	2017).	Carbonic	anhydrases	are	located	on	the	
basolateral	membrane	(CAXII	&	CAIX)	and	in	the	cytosol	(CAII),	and	aquaporin	1	
(AQP1)	is	expressed	on	the	apical	membrane	(Praetorius	&	Damkier,	2017).	By	
inactivating	NKCC1	on	the	apical	membrane,	there	is	a	decrease	in	Na+,	K+,	and	Cl-
influx,	along	with	associated	water.		This	imbalance	in	the	net	solute	and	water	
fluxes	results	in	CPECs	shrinking	until	the	net	solute	and	water	efflux	is	once	again	
balanced	with	the	net	influx,	and	the	new	steady-state	is	obtained.		Measurements	of	
CSA	of	freshly	dissociated	CPECs	from	NKCC1	-/-	mice	shows	they	are	~18	µm2	
smaller	than	those	from	WT	(Figure	4.2);	additionally,	inhibiting	NKCC1-mediated	
fluxes	with	bumetanide	(10	µM)	causes	a	decrease	in	CPEC	water	volume	by	-15.9	±	
9.1%,	(n	=	3	animals)	(Figure	4.3).	Using	live-cell	imaging	microscopy	the	research	
presented	here	extends	the	results	of	Wu	et	al.,	(1998)	by	resolving	the	precise	
change	in	CWV	that	occurs	when	NKCC1	is	inhibited	with	bumetanide.	Further,	
these	measurements	include	the	CSA	of	NKCC1	-/-	CPECs	(137	±	4.9	µm2,	n	=	22	
animals),	and	by	extrapolating	the	radii	and	treating	the	cells	as	hemispherical	
domes,	NKCC1	-/-	CPECs	have	a	predicted	volume	reduction	of	~16%	(Table	4.1).	In	
comparison	with	the	-15.9%	mean	CWV	reduction	observed	in	bumetanide	exposed	
WT	CPECs,	one	can	conclude	a	near	complete	inhibition	of	NKCC1	occurs	using	10	
µM	bumetanide.	Wu	et	al.,	(1998)	used	bumetanide	concentrations	as	high	as	100	
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µM	to	ensure	complete	inhibition	of	NKCC1,	which	can	lead	to	non-specific	
inhibition	of	other	cation	cotransporters	expressed	in	CPECs	such	as	apical	KCC4	
and	basolateral	KCC3a	(Alvarez-Leefmans,	2012).		
NKCC1-mediated	ion	and	associated	water	fluxes	are	essential	contributors	
to	CWV	regulation	in	both	polarized	and	symmetrical	cell	types	(Hamann	et	al.,	
2010;	Rocha-Gonzalez	et	al.,	2008;	Russell,	2000).	The	findings	presented	here	
demonstrate	that	NKCC1-mediated	fluxes	not	only	contribute	to	maintaining	the	
normal	and	constant	CWV	of	CPECS,	but	also	support	the	hypothesis	that	under	
basal	conditions	NKCC1	is	constitutively	active	in	CPECs.		When	a	cotransporter	is	
constitutively	active,	it	is	always	“on”,	constantly	working.		Almost	immediately	
upon	the	application	of	10	µM	bumetanide	WT	CPECs	begin	to	shrink	(Figure	4.3),	
indicating	that	NKCC1	is	actively	co-transporting	in	the	inward	direction	under	
basal	isosmotic	conditions.	This	response	is	in	contrast	to	what	is	found	some	other	
cell	types,	including	human	pigmented	retinal	epithelial	cells	and	dorsal	root	
ganglion	cells	(Hamann	et	al.,	2010;	Rocha-Gonzalez	et	al.,	2008;	Russell,	2000).	
Thus,	NKCC1	is	constitutively	active	in	CPECs.	Evidence	of	a	constitutively	active	
NKCC1	suggests	that	in	certain	cell	types,	such	as	CPECs,	the	cotransporter	has	a	
background	or	persistent	phosphorylation	state	that	contributes	to	cell	volume	
maintenance.		In	Cl-	transporting	secretory	epithelial	cells	of	exocrine	glands	(e.g.,	
salivary,	lacrimal,	airway	epithelium,	intestinal	crypts,	and	corneal	epithelium),	the	
direction	of	basolateral	NKCC1	cotransport	occurs	in	the	same	direction	as	epithelial	
secretion	and	NKCC1	participates	in	trans-cellular	Cl-	transport	and	CWV	
maintenance	(Haas	&	Forbush,	2000;	Hamann	et	al.,	2010;	Nakamoto	et	al.,	2007;	
	 78	
Silva	et	al.,	1977;	Walcott,	Birzgalis,	Moore,	&	Brink,	2005).	Interestingly,	apical	
NKCC1	cotransports	in	the	direction	opposite	to	that	expected	for	epithelial	
secretion	in	CPECs.	In	the	absence	of	external	Cl-,	CPECs	experienced	a	large	
decrease	in	CWV,	-20.3	±	1.8%	(n	=	10	animals),	presumably	due	to	cell	Cl-	depletion	
(Figure	4.4A).	NKCC1	-/-	CPECs	responded	to	external	Cl-	removal	with	a	more	
modest	decrease	in	CWV	of	-7.7	±	2.1%	(n	=	4	animals)	(Figure	4.4B),	which	
supports	NKCC1	-/-	CPECs	having	less	CWV	than	WT	(because	they	have	
significantly	less	Cl-	and	K+).	The	recovery	of	CWV	that	followed	Cl-	depletion	was	55	
-	78	%	(n	=	3	animals)	Na+-dependent	and	70	–	85	%	(n	=	3	animals)	bumetanide-
sensitive	in	CPECs	(Figure	4.4C,	D,	and	APPENDIX	B),	strengthening	the	notion	that	
NKCC1	contributes	to	cell	Cl-,	water	accumulation,	and	CWV	maintenance	and	it	
behaves	as	an	absorbing	epithelium.	Taken	together,	this	evidence	supports	the	
hypothesis	of	Specific	Aim	1:	A	function	of	NKCC1	in	CPECs	is	the	maintenance	of	
both	normal	and	constant	CWV.	Under	physiological	conditions	NKCC1	is	
constitutively	active,	inwardly	transporting	ions	and	associated	water.	
Measurements	of	[Cl-]i	in	single	CPECS	
	
Inhibiting	NKCC1	in	CPECs	with	bumetanide	is	shown	to	reduce	both	Cl-	
uptake	by	the	cells	and	Cl-	efflux	into	the	CSF	(Johanson	et	al.,	1990;	Johnson,	Singer,	
Hoop,	&	Kazemi,	1987;	Preston	et	al.,	1993).		NKCC1	-/-	CPECs	shrink	62%	less,	p	<	
0.01,	in	response	to	Cl-	depletion	compared	to	WT	CPECs	(Figure	4.4	A-B).		These	
results	suggest	NKCC1	-/-	CPECs	have	less	intracellular	[Cl-]	than	WT	cells.		To	test	
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this	hypothesis,	we	measured	the	[Cl-]i	of	individual	CPECs	isolated	from	both	WT	
and	NKCC1	-/-	mice	using	the	Cl-	indicator	MQAE,	and	find	that	NKCC1	-/-	CPECs	
have	approximately	half	the	[Cl-]i	as	WT	CPECs,	p	<	0.001	(Figure	5.3).	CPECs	from	
WT	have	a	mean	[Cl-]i	equal	to	62.1	±	3.5	mM	(n	=	5	animals)	and	NKCC1	-/-	CPECs	
have	a	mean	[Cl-]i	of	31.5	±	4.8	(n	=	7	animals).		This	decrease	in	[Cl-]i	of	NKCC1	-/-	
CPECs	is	in	agreement	with	the	findings	of	Johanson	et	al.,	(1990)	who	report	that	
(10	–100	µM)	bumetanide	reduces	CPEC	Cl-	uptake	by	~45%	(Johanson	et	al.,	1990).		
They	conclude	that	bumetanide	and	DIDS	(4,4-diisothiocyanatostilbene-2,2'-
disulfonic	acid,	an	inhibitor	of	Cl-/HCO3-	exchange)	equally	contribute	>90%	of	Cl-	
uptake	in	CPECs	(Johanson	et	al.,	1990).		Thus,	although	NKCC1	is	the	main	Cl-	
loader,	it	is	not	the	only	Cl-	loader.	For	instance,	anion	exchangers	known	to	be	
expressed	in	CPECs	(Lindsey	et	al.,	1990;	Wu	et	al.,	1998)	may	contribute	to	uphill	
intracellular	Cl-	accumulation.		
There	are	three	reported	values	of	CPEC	Em:	Rabbit	CPEC	have	a	Em	of	-64	mV	
across	the	ventricular	membrane	and	an	Em	of	-50	mV	across	the	basolateral	
membrane	(Welch	&	Sadler,	1965);	bullfrog	CPECs	have	a	Em	of	-47	mV	when	[K+]o	=	
2	mM	(Zeuthen	&	Wright,	1981);	and	rat	CPECs	have	an	Em	of	-53	mV	(Kotera	&	
Brown,	1994).		We	chose	Em	=	-53	mV,	measured	in	rat	CPECs	(Kotera	&	Brown,	
1994)	to	calculate	ECl	from	our	measurements	of	[Cl-]i.	The	mean	estimate	ECl	of	
NKCC1	+/+	CPECs	is	about	-19.71	±	1.4	mV,	which	is	more	depolarized	(less	
negative)	than	the	reported	Em	of	-53	mV,	suggesting	that	Cl-	is	maintained	above	
electrochemical	equilibrium	in	CPECs.	The	difference	between	ECl	–Em	(i.e.,	the	
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driving	force	for	Cl-)	is	~33	mV.	The	mean	ECl	in	NKCC1	-/-	CPECs	is	-38.9	±	4.2	mV	
(n=	7	animals),	therefore	[Cl-]i	appears	to	be	maintained	above	equilibrium	in	
NKCC1	KO	cells	as	well;	but	the	difference	ECl	–Em	is	about	13	mV,	one	third	of	that	
estimated	in	WT	cells.	Although	these	are	rough	estimates,	given	that	we	did	not	
measure	Em,	they	suggest	that	that	NKCC1	-/-	CPECs	have	a	mechanism	of	Cl-	uptake	
other	than	NKCC1.	Whether	or	not	this	mechanism	is	expressed	in	the	NKCC1	-/-	
due	to	a	compensatory	change	remains	to	be	determined.	In	their	most	recent	
review,	Praetorius	and	Damkier	propose	that	the	two	primary	Cl-	uptake	paths	in	
CPECs	are	apical	NKCC1	and	basolateral	anion	exchanger	2	(AE2)	(Praetorius	&	
Damkier,	2017),	so	this	would	point	to	AE2	being	the	other	Cl-	uptake	mechanism	
observed	in	the	NKCC1	-/-.		
Assuming	that	the	hypothesis	of	Praetorius	and	Damkier	(2017)	is	correct,	
then	CPECs	uptake	Cl-	on	both	the	apical	and	basolateral	membranes	(Figure	6.1).	
AE2	interacts	with	plasma	membrane	bound	carbonic	anhydrases,	and	AE2	activity	
is	affected	by	the	[HCO3-]	localized	near	the	basolateral	membrane	(Jeong	&	Hong,	
2016).		NKCC1	activity	is	regulated	by	the	phosphorylation	of	SPAK,	which	is	
abundantly	expressed	in	the	apical	membrane	of	CPECs	(Piechotta,	Lu,	&	Delpire,	
2002).	SPAK	phosphorylation	occurs	by	phosphorylated	WNK	kinases,	and	Cl-	can	
competitively	bind	to	the	catalytic	domain	of	WNKs	to	inhibit	their	auto-
phosphorylation,	and	consequently	inhibit	WNK	kinase	activity	(Piala	et	al.,	2014;	
Shekarabi	et	al.,	2017).		There	are	four	WNKs	(WNK1	–	4)	which	are	believed	to	act	
as	[Cl-]i	and/	or	volume	sensors	that	can	subsequently	modulate	the	activity	of	the	
slc12	family	of	cation-chloride	cotransporters	(Gagnon	&	Delpire,	2012;	Hadchouel,	
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Ellison,	&	Gamba,	2016;	Mercado	et	al.,	2016;	Piala	et	al.,	2014;	Shekarabi	et	al.,	
2017;	Terker	et	al.,	2016).		In	the	kidney,	Terker	and	colleagues	(2016)	find	that	
WNK4	is	inhibited	when	[Cl-]i	is	0	-40	mM,	WNK1	is	inhibited	when	[Cl-]i	is	60	–	150	
mM,	and	WNK3	is	inhibited	when	[Cl-]i	is	100	-150	mM	(Terker	et	al.,	2016).		WNK2	
is	not	included	in	this	list	because	it	is	only	found	in	the	brain	(Terker	et	al.,	2016),	
and	it	is	not	currently	known	if	WNK2	kinase	is	expressed	in	CPECs.		Given	the	CPEC	
[Cl-]i	of	62	mM,	one	would	hypothesize	that	WNK1	and	WNK3	could	control	the	set-
point	for	NKCC1-mediated	Cl-	uptake	and	KCC3-mediate	K-Cl	efflux,	since	WNK1	and	
WNK3	are	known	to	interact	with	both	NKCC1	and	KCC3	(Hadchouel	et	al.,	2016).	
Additionally,	changes	in	[K+]o	lead	to	changes	in	Cl-	efflux	and	[Cl-]i,	which	can	
modulate	the	phosphorylation	of	WNKs	(Shekarabi	et	al.,	2017),	supporting	NKCC1	
functioning	as	[K+]o	regulator.			
Measured	[Na+]i	in	single	CPECs	
	
Keep	et	al.,	(1994)	hypothesize	that	NKCC1	works	in	the	outward	under	basal	
conditions,	but	near	to	its	FRP,	when	[Na+]i	is	estimated	at	~30	mM	(Figure	5.2)	
(Keep	et	al.,	1994).		Wu	et	al.,	(1998)	estimate	a	similar	value	of	32.5	mM	using	
“volume	calculations”,	but	it	is	unclear	how	the	value	of	32.5	mM	is	obtained.		Smith	
and	Johanson	(1985)	report	that	CPEC	[Na+]i	=	34	–52	mM	and	Amin	et	al.,	(2009)	
report	a	value	of	35	mM,	it	should	be	noted	that	both	measurements	were	taken	
using	pieces	of	choroid	plexus	tissue,		Smith	and	Johanson	use	flame	photometry	
and	Amin	et	al.	use	Sodium	Green	fluorescence	of	choroidal	epithelia	containing	
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several	cells	(Amin	et	al.,	2009;	Smith	&	Johanson,	1985).		As	pointed	out	by	Minta	
and	Tsein	(1989),	measuring	[Na+]i	using	methods	that	measure	the	Na+	content	in	
whole	tissue	will	produce	erroneously	high	[Na+],	because	1)	both	intracellular	and	
extracellular	fluid	is	present	in	whole	tissue	making	it	difficult	to	assess	the	exact	
value	of	extra	and	intracellular	water,	particularly	in	a	tissue	composed	of	many	cell	
types	like	the	CP;	and	2)	methods	such	as	flame	photometry	measure	the	total	[Na+],	
i.e.,	free	plus	bound,	a	value	that	is	greater	than	the	intracellular	concentration	of	
free	Na+	(Minta	&	Tsien,	1989).	The	major	downside	to	the	methods	employed	by	
Johanson’s	group	is	that	they	use	an	estimate	of	percent	cell	water	(Murphy	&	
Johanson,	1990;	Smith	&	Johanson,	1985)	and	cannot	accurately	determine	the	ratio	
of	bound	vs	free	Na+	in	their	measurements,	nor	can	they	differentiate	between	
intra-	vs	extracellular	Na+	in	the	whole	tissue.	Similarly,	Amin	et	al.,	(2009)	loaded	
pieces	of	choroid	plexus	tissue	with	Sodium	Green	to	obtain	the	[Na+]	of	the	
epithelium	and	assume	its	equivalence	to	CPEC	[Na+]i	without	controlling	for	the	
presence	extracellular	fluid	or	the	vasculature.		
Using	the	recently	developed	Asante	Natrium	Green	2	indicator	from	
TEFLabs,	Inc.,	we	successfully	performed	the	first	[Na+]i	measurements	in	individual	
mammalian	CPECs.		Our	measurement	of	free	intracellular	[Na+]i	in	CPECs	is	8.4	±	
1.0	mM	(n	=	3	animals)	under	basal	conditions	(Figure	5.1).		With	this	[Na+]i	the	net	
free	energy	driving	NKCC1	transport	is	inwardly	directed	in	CPECs	(Figure	5.2).	
Additionally,	there	is	no	significant	difference	between	the	[Na+]i	of	WT	verses		
NKCC1	-/-	CPECs	(12.2	±	1.2	mM,	n	=	3	animals,	p	=	0.07).			
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Figure 6.1: Proposed model of NKCC1 function in CPECs under basal 
conditions.	CPECs not only secrete CSF but also regulate CSF [K+] using 
NKCC1. This homeostatic mechanism is crucial for normal brain function 
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because K+ freely diffuses between CSF and interstitial brain fluid. Modest 
elevations in CSF [K+] increases net inward ion and water transport mediated by 
NKCC1. CSF K+ is taken up into CPECs via NKCC1 & NKATP and either exits 
through basolateral KCC3a or is recycled back into the lumen by K+ channels 
(Brown et al., 2004; Praetorius & Damkier, 2017).  Na+ is recycled by the apical 
NKATP, and Cl- is partly recycled via apical Cl- channels and KCCs. Apical KCC4 
is only activated upon osmotic cell swelling, whereas basolateral KCC3a is 
constitutively active (Alvarez-Leefmans, 2012). This model is consistent with the 
notion that apical NKCC1 plays a key role in the reabsorption of K+ from CSF to 
blood and in the regulation of brain extracellular [K+]. 
	 85	
NKCC1	functions	as	a	sensor	and	regulator	of	CSF	[K+]	
	
It	is	known	that	CSF	K+	is	tightly	regulated	given	its	constant	concentration	in	
spite	of	variations	in	plasma	and	intraventricular	K+	(Ames	et	al.,	1965;	Bekaert	&	
Demeester,	1954;	Bradbury	&	Kleeman,	1967;	Cserr,	1965;	Husted	&	Reed,	1976).	
This	K+	regulation	occurs	independently	and	in	parallel	to	CSF	secretion	(Ames	et	al.,	
1965;	Cserr,	1965;	Husted	&	Reed,	1976).	CPECs	actively	uptake	K+	through	the	
combined	actions	of	NKATP	and	NKCC1,	both	located	on	the	apical	membrane	(see	
Figure	6.1)	(Bairamian	et	al.,	1991;	Parmelee	&	Johanson,	1989;	Saito	&	Wright,	
1987;	Wu	et	al.,	1998).	Husted	and	Reed	(1976)	propose	the	existence	of	a	
mechanism	in	the	CP	that	is	capable	of	regulating	CSF	[K+].		This	mechanism	enables	
CPECs	to	substantially	decrease	the	amount	of	K+	secreted	when	CSF	K+	is	high	(6.56	
mEq.	/l),	and	also	slightly	increase	the	amount	of	K+	secreted	when	CSF	K+	is	very	
low	(0.15	mEq.	/l)	(Husted	&	Reed,	1976).		However,	the	identity	of	this	CSF	[K+]	
regulation	mechanism	remained	to	be	determined.	Our	results	demonstrate	that	
freshly	dissociated	CPECs	are	exquisitely	sensitive	to	small	changes	in	[K+]o,	and	
CPECs	lose	this	K+	sensitivity	when	NKCC1-mediated	fluxes	are	removed	by	either	
pharmacological	inhibition	or	genetic	ablation.		By	modeling	the	net	free	energy	
driving	NKCC1	transport	(DµNKCC1)	with	respect	to	[K+]o,	we	find	DµNKCC1	to	be	
negative.	Thus,	apical	NKCC1	works	near	to	its	FRP	for	basal	K+	(2.9	mM)	but	in	the	
net	inward	mode,	FRP	occurs	[K+]o	»	1.4	-1.6	mM,	in	CPECs	(Figure	5.4).	NKCC1	has	
	 86	
a	Km	for	K+	of	2.7	mM	(Payne	&	Forbush,	1995),	thus	DµNKCC1	is	in	the	steep	part	of	
the	relation	in	the	range	near	basal	[K+]o	(Figure	5.4).		
Using	the	model	as	our	guide,	we	tested	the	CPEC	sensitivity	to	±	2	mM	K+	
with	respect	to	baseline	K+	(3	mM),	and	keeping	the	osmolality	of	the	solutions	
constant	(Figure	5.5).	When	we	increase	[K+]o	from	3	to	5	mM	CPECs	swell,	
increasing	their	volume	by	10.4	±	1.6%	(n	=	8	animals).	When	we	decrease	[K+]o	
from	3	to	1mM	CPECs	shrink,	decreasing	their	volume	by	-11.8	±	1.7%	(n	=	11	
animals).	When	we	repeat	these	experiments	using	NKCC1	-/-	CPECs,	there	is	no	
statistically	significant	response	to	either	1	or	5	mM	K+	(Figure	5.5).		Similarly,	WT	
CPECs	lose	their	ability	to	respond	to	±	2	mM	changes	in	[K+]o	when	NKCC1	activity	
is	blocked	with	10	µM	bumetanide	(Figure	5.6).		CPECs	maintain	HCO3-	above	
chemical	equilibrium,	and	HCO3-	is	important	for	CSF	secretion	as	inhibiting	
carbonic	anhydrase	(CA)	decreases	the	rate	of	CSF	production	by	30	–80	%	(Saito	&	
Wright,	1983,	1984;	Vogh	&	Langham,	1981).		Cl-/HCO3-	exchange	(AE2)	is	
modulated	by	plasma	membrane	bound	CA,	therefore	inhibiting	HCO3-	production	
decreases	Cl-	uptake	on	the	basolateral	membrane	(Jeong	&	Hong,	2016).	The	
physiological	saline	solutions	used	in	our	experiments	are	buffered	with	HEPES	and	
equilibrated	with	air.	Atmospheric	CO2	is	able	to	dissolve	into	the	solutions	where	it	
can	readily	enter	the	cell	and	convert	to	HCO3-	by	carbonic	anhydrases	present	
inside	the	cell	and	on	the	plasma	membrane	(Wright,	1978).		To	test	the	hypothesis	
that	using	HEPES	buffered	solutions	does	not	alter	the	ability	of	CPECs	to	respond	to	
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changes	in	[K+]o,	the	K+	experiments	are	repeated	using	CO2/HCO3-	buffered	saline	
solutions.			
In	the	presence	of	added	HCO3-	the	CWV	responses	to	±	2	mM	[K+]o	are	
slightly	larger	(Table	5.2)	but	not	statistically	different.		During	exposure	to	1	mM	K+	
CPECs	shrink	-13.1	±	2.3	%	(n	=	4	animals),	and	during	exposure	to	5	mM	K+	CPECs	
swell	16.6	±	2.9	%	(n	=	4	animals).		A	t-test	finds	no	difference	in	the	1	mM	K+	
responses	between	either	buffer,	p	=	0.69,	and	no	significant	difference	in	the	5	mM	
K+	responses,	p	=	0.07.	Altogether,	these	results	suggests	that	NKCC1	is	the	K+	
sensor	described	by	Husted	and	Reed	(1976)	and	supports	the	hypothesis	of	
Specific	Aim	2:	NKCC1	is	working	near	to	its	chemical	equilibrium	in	CPECs,	
therefore	small	changes	in	[K+]o	are	sufficient	to	alter	both	the	direction	and	
magnitude	of	NKCC1-mediated	ion	and	associated	water	fluxes.	
In	summary,	on	the	apical	membrane	of	CPECs,	NKATP	and	NKCC1	work	in	
concert	to	maintain	the	low	CSF	K+	concentration	(Figure	6.1).	However,	NKATP	
activity	alone	cannot	account	for	the	CSF	K+	sensing	and	regulating	abilities	of	
CPECs.		NKATPa1b1/b2	has	a	high	affinity	for	K+,	bring	in	two	K+	ions	per	cycle	with	
a	Km	for	external	K+	of	0.92	–1.16	mM;	whereas	NKCC1	has	a	lower	affinity	for	
external	K+,	Km	»	2.7mM,	and	uptakes	one	K+	ion	along	with	a	Na+	and	two	Cl-	ions	
(Brown	et	al.,	2004;	Crambert	et	al.,	2000;	Payne	&	Forbush,	1995;	Russell,	2000;	
Watts	et	al.,	1991).	So,	when	CSF	[K+]	is	~	3	mM,	NKATP	is	transporting	more	K+	into	
the	CPECs	than	NKCC1,	but	NKCC1	has	a	greater	response	rate	to	fluctuations	in	CSF	
[K+].	Together,	NKATP	and	NKCC1	bring	in	the	K+	and	Cl-	that	is	required	for	
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basolateral	K-Cl	efflux	via	KCC3a,	the	sole	K+	transporter	mechanism	on	the	
basolateral	membrane	of	CPECs	known	thus	far	(Praetorius	&	Damkier,	2017).		
NKATP	and	NKCC1	may	also	work	in	concert	to	regulate	CPEC	Na+	secretion,	with	
NKATP	acting	as	the	major	Na+	secretion	mechanism	and	Na+	efflux	regulation	
occurring	through	the	inward	transport	of	NKCC1	(Gagnon	&	Delpire,	2012).		Both	
[K+]o	and	[Na+]i	are	limited	in	their	respective	compartments	and	prone	to	
fluctuations	that	can	subsequently	alter	the	direction	of	net	ion	and	associated	
water	fluxes	mediated	by	NKCC1.	Increases	in	[Na+]i	occur	with	increases	in	[HCO3-]i	
(Zeuthen	&	Wright,	1981),	and	fluctuations	in	the	intracellular	ion	concentrations	
may	occur	during	normal	CSF	secretion.		Figure	6.2	illustrates	how	both	[K+]o	and	
[Na+]i	impact	the	direction	of	NKCC1	cotransport	in	CPECs.		The	graph	illustrates	
that	both	low	[Na+]i	and	high	[K+]o	promote	inwardly	directed	NKCC1	cotransport	in	
CPECs.	In	the	physiological	range,	when	[K+]o	is	2	–	4	mM	and	[Na+]i	is	10	–	20	mM,	
DµNKCC1	is	working	very	near	to	its	FRP	and	has	the	ability	to	reverse	the	direction	of	
transport	outwards	if	either	[Na+]i	becomes	too	high	or	[K+]o	becomes	too	low.		
Therefore,	the	[Na+]i	that	is	maintained	by	NKATP	can	influence	the	FRP	of	NKCC1	
with	respect	to	[K+]o	and	can	modulate	DµNKCC1.	The	NKATP	Na+	efflux	is	a	major	
driver	of	CSF	secretion,	as	ouabain	reduces	CSF	production,	and	this	points	to	the	
essential	roles	of	NKATP	in	maintaining	both	the	osmotic	and	electrochemical	
gradients	necessary	for	CSF	secretion	(Karimy	et	al.,	2016).		It	is	clear	that	both	
NKATP	and	NKCC1	are	important	contributors	to	CSF	secretion	and	regulation.		
Their	expression	on	the	apical	membrane	ensures	that	there	is	no	K+	uptake	by	
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CPECs	from	the	blood	(Figure	6.1).		The	ability	of	CPECs	to	recycle	K+	at	the	apical	
membrane	is	one	way	in	which	the	CSF	[K+]	is	maintained	at	2.9	mM.	
Under	basal	conditions	NKCC1	is	working	in	the	net	influx	mode	but	near	to	
its	FRP	for	external	K+,	which	Russell	(2000)	describes	as	under	±	1	KJ/	mol.		NKCC1	
working	near	its	FRP	is	normal	in	some	cells	types,	such	as	Ehrlich	ascites	tumor	
cells	and	bovine	aortic	endothelial	cells,	and	is	not	an	indication	that	the	
cotransporter	reverses	transport	direction	(Russell,	2000).		It	is	unlikely	that	[K+]CSF	
would	ever	become	low	enough	to	support	NKCC1	outward	transport.		Rare	cases	of	
lower	CSF	[K+]	do	occur	in	some	people	with	concomitant	presentation	of	
hypokalemia	schizophrenic-like	psychiatric	disorders	(Hatta	et	al.,	1999;	Lam,	Chau,	
&	Wing,	2009;	Plum,	1958).	However,	measured	CSF	[K+]	in	psychiatric	patients	
does	not	lower	more	than	3%	(Plum,	1958),	and	so	is	insufficient	to	reverse	the	
direction	of	NKCC1	transport.	Therefore,	we	propose	that	in	CPECs,	the	
cotransporter	functions	as	a	K+	absorption	mechanism	under	basal	conditions,	
similar	to	how	it	functions	in	glia	(Lu	et	al.,	2006;	Macaulay	&	Zeuthen,	2012).		Going	
back	to	the	work	of	Keep	and	colleagues	(1994),	we	find	a	few	retrospective	issues	
in	their	conclusions.		First,	Keep	et	al.,	inhibited	K-Cl	cotransport	with	R(+)-
butylindazone	(DOIA),	a	good	inhibitor	of	KCC3	and	poor	inhibitor	of	KCC4	
(Alvarez-Leefmans,	2012;	Keep	et	al.,	1994).	Additionally,	as	our	work	
demonstrates,	blocking	NKCC1-mediated	inward	ion	fluxes	decreases	[Cl-]i	that	
consequently	reduces	the	amount	of	Cl-	efflux.	If	CPECs	rely	on	KCCs	for	K+	efflux,	
then	reducing	the	[Cl-]i	would	both	reduce	the	available	cell	Cl-	and	promote	WNKs,	
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Figure 6.2: 3D Model of the FRP of NKCC1 in CPECs 
3-dimensional model of the direction of NKCC1 cotransport with respect to 
intracellular [Na+] and CSF [K+].  DµNKCC1 was calculated at 310 K, with [Na+]o = 
148 mM, [Cl-]o = 130 mM, [K+]o = 0 – 10 mM, [Na+]i = 0 – 50 mM, [Cl-]i = 62.1 mM, 
and [K+]i = 110 mM. Modeling FRP of NKCC1 with respect to [K+]o and [Na+]i , 
and on the right is a color guide for values of DµNKCC1. The dark green areas are 
when NKCC1 is working very near to its FRP.  As the color becomes blue, 
NKCC1 is working in the inward direction and farther away from its FRP.  Areas 
where the graph is yellow and red indicate that NKCC1 is working in the outward 
direction and away from its FRP—acting solely in the ion secretion mode. 
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and	subsequently	SPAK	and	KCC,	phosphorylation	that	deactivates	KCC	K+	efflux.		
Keep	et	al.,	(1994)	proposed	NKCC1	working	near	flux	reversal	as	an	explanation	of	
their	results	and	those	of	Javaheri	and	Wagner	(1993),	who	demonstrate	that	
intraventricular	bumetanide	decreases	CSF	secretion.	We	propose	that	the	
explanation	is	that	the	constitutively	active	apical	NKCC1	cotransporter	on	CPECs	
functions	to	maintain	both	[Cl-]i	and	CWV	that	is	necessary	for	normal	CSF	secretion	
and	K+	absorption.		NKCC1	is	likely	able	to	sense	and	regulate	the	[K+]o	through	[Cl-
]i,	similarly	to	the	Na+/	Cl-	symporter	(Shekarabi	et	al.,	2017).		The	low	[K+]o	of	the	
CSF	promotes	apical	Cl-	efflux	by	maintaining	a	hyperpolarized	membrane	potential	
that	is	more	negative	than	ECl	(Frizzell	&	Hanrahan,	2012;	Russell,	2000).	Changes	in	
[K+]o	lead	to	changes	in	[Cl-]i	and	cell	volume,	thereby	modulating	the	reciprocal	
phosphorylation	states	of	WNKs,	SPAK,	NKCC1,	KCC3,	and	KCC4	(Shekarabi	et	al.,	
2017).		
Future	Directions	
	
NKCC1	inhibition	is	currently	under	investigation	as	a	treatment	strategy	to	
reduce	cytotoxic	edema/	glial	swelling	and	promote	neurogenesis	following	brain	
injuries	(Begum	et	al.,	2015;	Glykys	et	al.,	2017;	Hertz	&	Chen,	2016;	Hui	et	al.,	2016;	
Jantzie	et	al.,	2015;	Jayakumar	et	al.,	2011;	Kahle	et	al.,	2009;	Wang,	Huang,	He,	
Ruan,	&	Huang,	2014;	Zhang,	Pu,	et	al.,	2017).	Recent	research	points	to	WNK3	and	
SPAK	as	excellent	drug	targets	to	reduce	cytotoxic	edema	and	improve	recovery	
(Zhao	et	al.,	2017).	In	a	focal	ischemic	stroke	model	WNK3	-/-,	SPAK	-/-,	and	SPAK	
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+/-	mice	have	a	>	50%	reduction	in	lesion	size	and	improved	recovery	compared	to	
WT	mice	(Zhao	et	al.,	2017).		While	it	appears	that	inhibition	of	NKCC1	or	its	
regulatory	kinases	improves	brain	injury	outcome	and	recovery,	this	NKCC1	
inactivation	means	there	will	be	an	increase	in	brain	[K+]o	that	will	have	to	be	
removed.			It	is	critical	to	understand	how	NKCC1/SPAK/WNKs	inhibition	in	the	
brain	parenchyma	can	affect	the	ability	of	the	choroid	plexus	to	absorb	excess	K+	
and	secrete	CSF.	NKCC1	contributes	indirectly	to	CSF	secretion	and	can	be	a	drug	
target	to	reduce	CSF	production.		Further	work	is	also	needed	to	develop	a	drug	
capable	of	crossing	the	blood-brain	and	blood-CSF	barriers	to	inhibit	NKCC1	directly	
or	inactivate	SPAK	or	WNKs	(Zhang,	Karimy,	Delpire,	&	Kahle,	2017).	By	analyzing	
the	CSF	composition	and	neuronal	function	of	the	NKCC1	-/-	mouse,	the	
consequence	of	NKCC1	inhibition	in	the	brain	will	be	better	understood.		Also,	it	
would	then	be	possible	to	test	how	NKCC1	-/-	respond	to	increases	in	CSF	K+	from	
injury,	and	whether	the	decrease	in	CSF	production	helps	with	brain	edema.	The	use	
of	knockout	animals	is	increasingly	more	common	and	it	is	critical	to	have	a	
thorough	understanding	of	the	physiology	of	these	animals.		Preliminary	work	
verifies	the	expression	of	NKATPa1	and	AQP1	on	the	apical	membrane	of	NKCC1	-/-	
CPECs	(see	Appendix	A),	and	more	work	is	needed	to	complete	the	screening	by	
including	all	K+	cotransporters,	and	performing	a	quantitative	fluorescence	intensity	
analysis.	Further,	measuring	the	CPEC	[K+]i	using	Asante	Potassium	Green	
(TEFLabs)	is	necessary	to	complete	the	model	of	NKCC1	cotransport	so	that	
computer	models	of	NKCC1	transport	can	be	used	in	place	of	animals.		All	
intracellular	ion	measurements	need	repeating	using	bicarbonate-buffered	aCSF	as	
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control,	as	well	as	test	solutions	which	are	buffered	using	a	combination	of	both	
HEPES	and	bicarbonate.			
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APPENDIX	A	
Pilot	Experiment,	Immunohistochemical	verification	of	the	
expression	of	NKATPa1	and	AQP1	in	NKCC1	-/-	CPECs.	
	
AQP1	and	NKATP	are	both	expressed	on	the	apical	membrane	of	CPECs	(Wu	
et	al.,	1998).	Given	that	AQP1	is	the	only	known	water	channel	expressed	in	on	the	
apical	membrane	of	CPECs,	and	that	NKATP	is	the	other	K+	uptake	mechanism	with	
an	unusual	location	in	this	secretory	epithelial	cell,	we	decided	to	perform	a	
screening	to	determine	whether	the	location	of	either	of	these	membrane	proteins	
was	changed	in	the	NKCC1	-/-	mouse.	A	change	in	the	location	of	either	AQP1	or	
NKATP	in	the	NKCC1	-/-	mouse	would	suggest	that	NKCC1	somehow	participates	in	
membrane	protein	sorting.		The	ultimate	goal	of	this	screening	is	to	compare	all	of	
the	known	ion	transporters	in	the	NKCC1	-/-	mouse	CP	to	WT	controls;	however,	we	
chose	to	begin	with	the	two	apical	proteins	that	may	interact	with	the	K+-induced	
changes	in	CWV	presented	above.	The	expression	pattern	of	both	AQP1	and	NKATP	
in	CPECs	from	NKCC1	KO	mice	appeared	to	be	the	same	as	in	WT,	n	=	1	(Figure	A1).		
There	may	be	a	difference	the	intensity	of	the	antibody	staining	in	the	NKCC1	-/-	
mouse,	which	supports	further	investigation	to	quantify	the	fluorescence.
	 114	
			
Figure A1: NKCC1 KO CPECs maintain their apical expression of 
NKATPa1 and AQP1.	Brain tissue obtained from male sibling WT and 
NKCC1 -/- mice, postnatal age 19 days.  A and B revealed the apical 
expression pattern of NKATPa1 on the CP in WT (A) and NKCC1 KO (B).  
In C and D, a similar apical expression pattern existed for CP from the WT 
(C) and NKCC1 -/- (D).
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APPENDIX	B	
Animal	means	from	the	experimental	data.	
	
	 The	following	supplemental	data	of	the	individual	animal	statistics	is	
presented	in	the	same	order	as	it	appears	in	the	main	text.		Data	labels	show	
the	individual	animal	means	±	standard	deviations,	with	n	=	number	of	cells	
from	that	animal.		
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Figure B1: WT and NKCC1 KO cross-sectional area animal data. Individual 
statistics presented in tables on the following pages with left to right graph data 
presented top to bottom in table.	
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Table	B1A:	WT	cross-sectional	Areas	(CSA)	
Animal	ID	 n	=	cells	 Mean	CSA	(μm2)	 standard	deviation	
12.2	 9	 123.4233	 17.6	
12.1	 12	 110.158	 24.4	
8.3	 7	 172.8159	 21.1	
6.4	 6	 164.9738	 31.3	
9.4	 7	 154.9809	 17.9	
7.3	 5	 142.6804	 11.9	
36.2	 7	 160.6699	 21.5	
40.6	 15	 201.1547	 37.0	
40.3	 6	 138.0045	 8.8	
40.1	 9	 169.6126	 31.9	
38.1	 9	 206.1038	 42.9	
38.3	 7	 157.5668	 14.5	
36.5	 11	 162.8289	 29.2	
16.4	 7	 167.9831	 23.9	
7.6	 7	 132.0074	 11.7	
2.1	 8	 170.7131	 20.8	
2.2	 6	 169.3866	 17.0	
85.6	 5	 117.0302	 11.4	
76.2	 9	 163.3088	 21.8	
75.6	 7	 125.1456	 21.6	
72.1	 9	 158.1353	 22.9	
69.3	 7	 171.9388	 43.7	
50.1	 4	 192.7865	 18.0	
48.5	 16	 172.1032	 39.5	
48.4	 16	 123.9412	 25.4	
47.4	 13	 168.7268	 35.7	
46.6	 10	 147.9214	 24.9	
44.7	 9	 149.7962	 31.8	
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42.5	 16	 107.9828	 31.6	
37.5	 24	 194.9336	 47.6	
36.6	 10	 129.0399	 29.6	
33.5	 12	 147.3018	 36.6	
33.4	 17	 117.2521	 16.6	
32.5	 5	 96.7644	 9.6	
29.2	 8	 134.1625	 15.3	
26.7	 15	 163.2957	 19.0	
4.6	 5	 188.6032	 25.3	
80.3	 6	 209.4189	 61.0	
78.2	 13	 194.7071	 54.4	
77.1	 7	 153.8979	 15.0	
75.1	 30	 150.6935	 34.7	
74.2	 28	 171.6309	 32.4	
68.6	 15	 143.0997	 34.4	
44.2	 36	 128.4247	 29.6	
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Table	B1B:		NKCC1	KO	cross-sectional	areas	(CSA)	
Animal	ID	 n	=	cells	 Mean	CSA	(µm2)	 standard	deviation	
71.1	 4	 132.4749	 21.6	
70.9	 7	 148.005	 19.6	
70.7	 3	 133.1665	 29.4	
63.4	 2	 191.1266	 3.5	
14.6	 9	 137.6215	 33.0	
62.2	 11	 162.6473	 29.6	
41.2	 14	 151.9135	 22.2	
41.4	 12	 159.4426	 23.2	
34.1	 9	 134.7757	 16.7	
33.8	 9	 128.9164	 45.6	
20.1	 15	 168.2091	 28.9	
19.2	 21	 125.3188	 22.8	
10.1	 20	 132.7343	 17.9	
4.5	 11	 125.2148	 24.7	
83.1	 8	 110.6741	 15.1	
83.4	 13	 125.8348	 26.8	
67.3	 22	 126.7616	 35.5	
47.2	 21	 151.5516	 35.6	
21.1	 11	 95.5485	 38.3	
12.2	 17	 157.6301	 42.0	
12.5	 10	 104.8059	 17.0	
6.4	 15	 117.6413	 8.9	
	
	 120	
	
Figure	B2:	CPEC	volume	response	to	10	µM	bumetanide	
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Figure	B3:	CPEC	volume	response	to	0Cl	
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Figure	B4:	CPEC	volume	recovery	from	0Cl.	
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Figure	B5:	ANG-2	[Na+]i	measurements	
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Figure	B6:	MQAE	[Cl-]i	measurements	
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Figure	B7:	CPEC	volume	response	to	1	mM	K+	
WT 1 mM K+ Response Individual Animal Means 
Vo
lu
m
e 
C
ha
ng
e 
(%
)
-30
-20
-10
0
10
-18.2 ± 4.3, n = 16
KO 1 mM K+ Response Individual Animal Means 
Vo
lu
m
e 
C
ha
ng
e 
(%
)
-30
-20
-10
0
10
0.6 ± 2.9 
n = 5
-0.9 ± 0.3 
n = 6
0.7 ± 1.7 
n = 4
Mean ± SD, n = number of cells
Mean ± SD, n = number of cells
-24.2 ± 4.5, n = 9
-7.8 ± 0.5, n = 5
-16.0 ± 1.5, n = 4
-11.2 ± 1.3, n = 3
-11.5, n = 1
-8.2 ± 1.5, n = 3
-12.4, n = 1
-6.5 ± 0.6, n = 3
-7.5 ± 0.9, n = 4
-6.0 ± 0.9, n = 3
	 126	
	
Figure	B8:	CPEC	volume	response	to	5	mM	K+	
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Figure	B9:	CPEC	volume	response	to	1	and	5	mM	K+	in	HCO3-	buffered	solutions.	
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